Seagate Technology (STX) 10-K 2 Aug 24 2024 FY Annual report Financial data

Cover

Cover - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jul. 30, 2024	Dec. 31, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 28, 2024
Document Transition Report	false
Entity File Number	001-31560
Entity Incorporation, State or Country Code	L2
Entity Tax Identification Number	98-1597419
Entity Address, Address Line One	121 Woodlands Avenue 5
Entity Address, City or Town	Singapore
Entity Address, Country	SG
Entity Address, Postal Zip Code	739009
City Area Code	65
Local Phone Number	6018-2562
Title of 12(b) Security	Ordinary Shares, par value $0.00001 per share
Trading Symbol	STX
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 17,800
Entity Common Stock, Shares Outstanding		210,195,239
Documents Incorporated by Reference	Portions of the definitive proxy statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A relating to the registrant’s Annual General Meeting of Shareholders, to be held on October 19, 2024, will be incorporated by reference in this Form 10-K in response to Items 10, 11, 12, 13 and 14 of Part III. The definitive proxy statement will be filed with the SEC no later than 120 days after the registrant's fiscal year ended June 28, 2024.
Entity Registrant Name	Seagate Technology Holdings plc
Entity Central Index Key	0001137789
Amendment Flag	false
Current Fiscal Year End Date	--06-28
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Jun. 28, 2024
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	San Jose, California

Legal, Environmental and Other

Legal, Environmental and Other Contingencies	12 Months Ended
	Jun. 28, 2024
Legal, Environmental and Other Contingencies Disclosure [Abstract]
Legal, Environmental and Other Contingencies	Legal, Environmental and Other Contingencies The Company assesses the probability of an unfavorable outcome of all its material litigation, claims or assessments to determine whether a liability had been incurred and whether it is probable that one or more future events will occur confirming the fact of the loss. In the event that an unfavorable outcome is determined to be probable and the amount of the loss can be reasonably estimated, the Company establishes an accrual for the litigation, claim or assessment. In addition, in the event an unfavorable outcome is determined to be less than probable, but reasonably possible, the Company will disclose an estimate of the possible loss or range of such loss; however, when a reasonable estimate cannot be made, the Company will provide disclosure to that effect. Litigation is inherently uncertain and may result in adverse rulings or decisions. Additionally, the Company may enter into settlements or be subject to judgments that may, individually or in the aggregate, have a material adverse effect on its results of operations. Accordingly, actual results could differ materially. Litigation Lambeth Magnetic Structures LLC v. Seagate Technology (US) Holdings, Inc., et al. On April 29, 2016, Lambeth Magnetic Structures LLC filed a complaint against Seagate Technology (US) Holdings, Inc. and Seagate Technology LLC in the U.S. District Court for the Western District of Pennsylvania, alleging infringement of U.S. Patent No. 7,128,988, “Magnetic Material Structures, Devices and Methods,” seeking damages as well as additional relief. The district court entered judgment in favor of Seagate on April 19, 2022, following a jury trial. The parties filed post-trial motions with the district court, which were denied. An appeal to the Federal Circuit is pending. The Company believes the asserted claims are without merit and intends to vigorously defend this case. Seagate Technology LLC, et al. v. Headway Technologies, Inc., et al. On February 18, 2020, Seagate Technology LLC, Seagate Technology (Thailand) Ltd., Seagate Singapore International Headquarters Pte. Ltd. and Seagate Technology International (collectively, the “Seagate Entities”) filed a complaint in the U.S. District Court for the Northern District of California against defendant suppliers of HDD suspension assemblies. Defendants include NHK Spring Co. Ltd., TDK Corporation, Hutchinson Technology Inc. and several of their subsidiaries and affiliates. The complaint includes federal and state antitrust law claims, as well as a breach of contract claim. The complaint alleges that defendants and their co-conspirators knowingly conspired for more than twelve years not to compete in the supply of suspension assemblies; that defendant misused confidential information that the Seagate Entities had provided pursuant to nondisclosure agreements, in breach of their contractual obligations; and that the Seagate Entities paid artificially high prices on purchases of suspension assemblies. The Seagate Entities seek to recover the overcharges they paid for suspension assemblies, and additional relief permitted by law. On March 22, 2022, the Seagate Entities dismissed with prejudice all claims being asserted against Defendants TDK Corporation, Hutchinson Technology Inc. and their subsidiaries and affiliates (collectively “TDK”) relating to the antitrust law claims, the breach of contract claim and other matters described in the complaint. On April 8, 2022, the court entered an Amended Stipulation and Order of Dismissal with Prejudice to dismiss all claims against TDK. On August 2, 2022, NHK Spring Co. Ltd. filed a motion for Partial Summary Judgment under the Foreign Trade Antitrust Improvement Act (“FTAIA Motion”) against Seagate’s antitrust claims, and on October 14, 2022, the Seagate Entities filed their corresponding opposition. On May 15, 2023, the court issued a ruling that Seagate’s antitrust claims can proceed as to suspension assemblies that enter the United States but not as to suspension assembles that do not enter the United States. On July 28, 2023, the District Court initiated a reconsideration of this ruling and requested further briefing. On November 17, 2023, the Court granted NHK’s FTAIA Motion and denied Seagate’s Motion for Leave to Amend the Complaint. Seagate filed a motion on December 15, 2023 for the Court to certify the ruling for interlocutory appeal. On April 22, 2024, the District Court granted in part and denied in part Seagate’s motion to certify for interlocutory appeal the Court’s ruling on NHK’s FTAIA Motion. On May 2, 2024, Seagate filed a Petition for Permission to Appeal to the Ninth Circuit. On July 18, 2024, the United States Court of Appeals for the Ninth Circuit issued an order granting Seagate’s Petition for Permission to Appeal. In re Seagate Technology Holdings plc Securities Litigation. A putative class action lawsuit alleging violations of the federal securities laws, UA Local 38 Defined Contribution Pension Plan, et al. v. Seagate Technology Holdings PLC, et al ., was filed on July 10, 2023, in the U.S. District Court for the Northern District of California against Seagate Technology Holdings plc, Dr. William D. Mosley, and Gianluca Romano. The complaint alleged that it was a securities class action on behalf of all purchasers of Seagate common stock between September 15, 2020 and October 25, 2022, inclusive, and asserted claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b5-1. The complaint sought unspecified monetary damages and other relief. A second action, Public Employees’ Retirement System of Mississippi v. Seagate Technology Holdings plc, William David Mosley, and Gianluca Romano , was filed on July 26, 2023, asserting similar claims. The cases were consolidated on September 25, 2023. On October 19, 2023, plaintiffs filed an amended complaint asserting similar claims with a putative class period of September 14, 2020 through April 19, 2023. The Company, on behalf of all defendants, filed a motion to dismiss the amended complaint, which is currently pending before the court. A hearing regarding Seagate’s motion to dismiss occurred on March 26, 2024. The Company believes that the asserted claims are without merit and intends to vigorously defend the case. Godo Kaisha IP Bridge 1 v. Seagate Technology LLC, Seagate Technology (US) Holding, Inc., Seagate Technology (Thailand) Limited, Seagate Singapore International Headquarters Ltd., Seagate Technology (Netherlands) B.V. On March 15, 2024, a patent infringement action was filed by Godo Kaisha IP Bridge 1 (“IP Bridge”) against Seagate in U.S. District Court for the District of Delaware. The complaint alleges patent infringement by Seagate of three U.S. patents. On June 7, 2024, Seagate filed a motion to dismiss and a motion to transfer venue to Minnesota. On July 8, 2024, IP Bridge filed a First Amended Complaint alleging patent infringement by Seagate of six additional patents. IP Bridge is seeking damages as well as additional relief. The Company believes the asserted claims are without merit and intends to vigorously defend this case. Environmental Matters The Company’s operations are subject to U.S. and foreign laws and regulations relating to the protection of the environment, including those governing discharges of pollutants into the air and water, the management and disposal of hazardous substances and wastes and the cleanup of contaminated sites. Some of the Company’s operations require environmental permits and controls to prevent and reduce air and water pollution, and these permits are subject to modification, renewal and revocation by issuing authorities. The Company has established an environmental management system and continually review and update environmental policies and standard operating procedures for operations worldwide as needed. The Company believes that its operations are in material compliance with applicable environmental laws, regulations and permits. The Company budgets for operating and capital costs on an ongoing basis to comply with environmental laws. If additional or more stringent requirements are imposed on the Company in the future, it could incur additional operating costs and capital expenditures. Some environmental laws, such as the Comprehensive Environmental Response Compensation and Liability Act of 1980 (as amended, the “Superfund” law) and its state equivalents, can impose liability for the cost of cleanup of contaminated sites upon any of the current or former site owners or operators or upon parties who sent waste to these sites, regardless of whether the owner or operator owned the site at the time of the release of hazardous substances or the lawfulness of the original disposal activity. The Company has been identified as a responsible or potentially responsible party at several sites. At each of these sites, the Company has an assigned portion of the financial liability based on the type and amount of hazardous substances disposed of by each party at the site and the number of financially viable parties. The Company has fulfilled its responsibilities at some of these sites and remains involved in only a few at this time. While the Company’s ultimate costs in connection with these sites is difficult to predict with complete accuracy, based on its current estimates of cleanup costs and its expected allocation of these costs, the Company does not expect costs in connection with these sites to be material. The Company may be subject to various state, federal and international laws and regulations governing the environment, including those restricting the presence of certain substances in electronic products. For example, the European Union (“EU”) enacted the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU), which prohibits the use of certain substances, including lead, in certain products, including disk drives and server storage products, put on the market after July 1, 2006. Similar legislation has been or may be enacted in other jurisdictions, including in the United States, Canada, Mexico, Taiwan, China, Japan and others. The EU REACH Directive (Registration, Evaluation, Authorization, and Restriction of Chemicals, EC 1907/2006) also restricts substances of very high concern in products. If the Company or its suppliers fail to comply with the substance restrictions, recycle content requirements or other environmental requirements as they are enacted worldwide, it could have a materially adverse effect on the Company’s business. BIS Settlement On April 18, 2023, the Company’s subsidiaries Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd (collectively, “Seagate”), entered into a settlement agreement (the “Settlement Agreement”) with the U.S. Department of Commerce’s Bureau of Industry and Security (“BIS”) that resolves BIS’ allegations regarding Seagate’s sales of hard disk drives to Huawei between August 17, 2020 and September 29, 2021. Under the terms of the Settlement Agreement, Seagate has agreed to pay $300 million to BIS in quarterly installments of $15 million over the course of five years beginning October 31, 2023. Seagate has also agreed to complete three audits of its compliance with the license requirements of Section 734.9 of the U.S. Export Administration Regulations (“EAR”), including one audit by an unaffiliated third-party consultant chosen by Seagate with expertise in U.S. export control laws and two internal audits. The Settlement Agreement also includes a denial order that is suspended and will be waived five years after the date of the order issued under the Settlement Agreement, provided that Seagate has made full and timely payments under the Settlement Agreement and timely completed the audit requirements. While Seagate is in compliance with and upon successful compliance in full with the terms of the Settlement Agreement, BIS has agreed it will not initiate any further administrative proceedings against Seagate in connection with any violation of the EAR arising out of the transactions detailed in the Settlement Agreement. While Seagate believed that it complied with all relevant export control laws at the time it made the hard disk drive sales at issue, Seagate determined that engaging with BIS and settling this matter was in the best interest of the Company, its customers, and its shareholders. In determining to engage with BIS and resolve this matter through a settlement agreement, the Company considered a number of factors, including the risks and cost of protracted litigation involving the U.S. government, and the size of the potential penalty and the Company’s desire to focus on current business challenges and long-term business strategy. The Settlement Agreement includes a finding that the Company incorrectly interpreted the regulation at issue to require evaluation of only the last stage of Seagate’s hard disk drive manufacturing process rather than the entire process. As part of this settlement, Seagate has agreed not to contest BIS’ determination that the sales in question did not comply with the U.S. EAR. The Company accrued a charge of $300 million during fiscal year 2023, of which $60 million and $195 million were included in Accrued expense and Other non-current liabilities, respectively, on the Consolidated Balance Sheets as of June 28, 2024. For the fiscal year ended 2024, $45 million was paid and reported as an outflow from operating activities in its Consolidated Statements of Cash Flows. Other Matters

Legal, Environmental and Othe_2

Legal, Environmental and Other Contingencies (Details) $ in Millions		12 Months Ended
	Apr. 18, 2023 USD ($) audit	Jun. 28, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jul. 01, 2022 USD ($)
Loss Contingencies [Line Items]
Litigation settlement amount	$ 300
Litigation settlement payments, quarterly installments amount	$ 15
Litigation settlement, number of years of payment	5 years
Litigation settlement, number of audits | audit	3
Litigation settlement, number of third-party audits | audit	1
Litigation settlement, number of internal audits | audit	2
Denial order waiver period	5 years
Loss contingency, loss in period		$ 0	$ 300	$ 0
Accrued Liabilities [Member]
Loss Contingencies [Line Items]
Litigation settlement, amount accrued		60
Other Noncurrent Liabilities
Loss Contingencies [Line Items]
Litigation settlement, amount accrued		$ 195

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Current assets:
Cash and cash equivalents	$ 1,358	$ 786
Accounts receivable, net	429	621
Inventories, net	1,239	1,140
Other current assets	306	358
Total current assets	3,332	2,905
Property, equipment and leasehold improvements, net	1,614	1,706
Other intangible assets	1,219	1,237
Other assets, net	1,037	1,117
Total Assets	537	591
Total Assets	7,739	7,556
Current liabilities:
Accounts payable	1,786	1,603
Accrued employee compensation	106	100
Accrued warranty	74	78
Current portion of long-term debt	479	63
Accrued expenses	654	748
Total current liabilities	3,099	2,592
Long-term accrued warranty	75	90
Other non-current liabilities	861	685
Long-term debt, less current portion	5,195	5,388
Total Liabilities	9,230	8,755
Seagate Technology plc shareholders' equity:
Ordinary shares and additional paid-in capital	7,471	7,373
Accumulated other comprehensive (loss) income	(2)	98
Accumulated deficit	(8,960)	(8,670)
Total Shareholders’ Deficit	(1,491)	(1,199)
Total Liabilities and Shareholders’ Deficit	$ 7,739	$ 7,556

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Income Statement [Abstract]
Revenue	$ 6,551	$ 7,384	$ 11,661
Cost of revenue	5,015	6,033	8,192
Product development	654	797	941
Marketing and administrative	460	491	559
Amortization of intangibles	0	3	11
BIS settlement penalty	0	300	0
Restructuring and other, net	(30)	102	3
Total operating expenses	6,099	7,726	9,706
Income (loss) from operations	452	(342)	1,955
Interest income	15	10	2
Interest expense	(332)	(313)	(249)
Net gain from termination of interest rate swap	104	0	0
Net gain from business divestiture	313	0	0
Net (loss) gain from early redemption of debt	(29)	190	0
Other, net	(78)	(41)	(29)
Other expense, net	(7)	(154)	(276)
Income (loss) before income taxes	445	(496)	1,679
Provision for income taxes	110	33	30
Net income (loss)	$ 335	$ (529)	$ 1,649
Net income (loss) per share:
Basic (in dollars per share)	$ 1.60	$ (2.56)	$ 7.50
Diluted (in dollars per share)	$ 1.58	$ (2.56)	$ 7.36
Number of shares used in per share calculations:
Basic (in shares)	209,000	207,000	220,000
Diluted (in shares)	212,000	207,000	224,000

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Net income (loss)	$ 335	$ (529)	$ 1,649
Change in net unrealized (losses) gains on cash flow hedges:
Net change	(103)	52
Change in unrealized components of post-retirement plans:
Net change	(2)	(10)
Foreign currency translation adjustments	1	0	0
Total other comprehensive (loss) income, net of tax	(100)	62	77
Comprehensive income (loss)	235	(467)	1,726
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent
Change in net unrealized (losses) gains on cash flow hedges:
Net unrealized (losses) gains arising during the period	(13)	65	48
(Gains) losses reclassified into earnings	(90)	(13)	21
Net change	(103)	52	69
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Change in unrealized components of post-retirement plans:
Net unrealized gains arising during the period	1	11	6
Losses (gains) reclassified into earnings	1	(1)	2
Net change	$ (2)	$ (10)	$ (8)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
OPERATING ACTIVITIES
Net income (loss)	$ 335	$ (529)	$ 1,649
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	264	513	451
Share-based compensation	127	115	145
Net loss (gain) from redemption and repurchase of debt	7	(204)	0
Net gain from business divestiture	313	0	0
Deferred income taxes	78	10	(9)
Other non-cash operating activities, net	34	(125)	64
Changes in operating assets and liabilities:
Accounts receivable, net	192	911	(374)
Inventories, net	(99)	425	(361)
Accounts payable	227	(421)	228
Accrued employee compensation	6	(152)	(30)
BIS settlement penalty	(45)	0	0
Accrued expenses, income taxes and warranty	(138)	101	(26)
Other assets and liabilities	243	298	(80)
Net cash provided by operating activities	918	942	1,657
INVESTING ACTIVITIES
Acquisition of property, equipment and leasehold improvements	(254)	(316)	(381)
Proceeds from the sale of assets	40	534	0
Purchases of investments	0	(1)	(18)
Proceeds from sale of investments	14	0	47
Proceeds from business divestiture	326	0	0
Net cash provided by (used in) investing activities	126	217	(352)
FINANCING ACTIVITIES
Redemption and repurchase of debt	(1,288)	(1,578)	(701)
Dividends to shareholders	(585)	(582)	(610)
Repurchases of ordinary shares	0	(408)	(1,799)
Taxes paid related to net share settlement of equity awards	(38)	(44)	(51)
Proceeds from issuance of long-term debt	1,500	1,600	1,200
Proceeds from issuance of ordinary shares under employee stock plans	66	68	68
Other financing activities, net	(128)	(44)	(6)
Net cash used in financing activities	(473)	(988)	(1,899)
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash	1	0	0
Increase (decrease) in cash, cash equivalents and restricted cash	572	171	(594)
Cash, cash equivalents and restricted cash at the beginning of the year	788	617	1,211
Cash, cash equivalents and restricted cash at the end of the year	1,360	788	617
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	303	327	244
Cash paid for income taxes, net of refunds	$ 30	$ 32	$ 33

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Starting Balance (in shares) at Jul. 02, 2021		227
Total Seagate Technology plc Shareholders' Equity, Starting Balance at Jul. 02, 2021	$ 631	$ 0	$ 6,977	$ (41)	$ (6,305)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	1,649				1,649
Other comprehensive loss	77			77
Issuance of ordinary shares under employee stock plans (in shares)		4
Issuance of ordinary shares under employee stock plans	68		68
Repurchases of shares (in shares)		(20)
Repurchases of shares	$ (1,806)				(1,806)
Tax withholding related to vesting of restricted stock units (in shares)	(1)	(1)
Tax withholding related to vesting of restricted share units	$ (51)				(51)
Dividends to shareholders	(604)				(604)
Share-based compensation	145		145
Ending Balance (in shares) at Jul. 01, 2022		210
Total Seagate Technology plc Shareholders' Equity, Ending Balance at Jul. 01, 2022	$ 109	$ 0	7,190	36	(7,117)
Increase (Decrease) in Stockholders' Equity
Common stock, dividends, per share, declared (in dollars per share)	$ 2,770,000
Net income (loss)	$ (529)				(529)
Other comprehensive loss	62			62
Issuance of ordinary shares under employee stock plans (in shares)		3
Issuance of ordinary shares under employee stock plans	68		68
Repurchases of shares (in shares)		(5)
Repurchases of shares	$ (400)				(400)
Tax withholding related to vesting of restricted stock units (in shares)	(1)	(1)
Tax withholding related to vesting of restricted share units	$ (44)				(44)
Dividends to shareholders	(580)				(580)
Share-based compensation	115		115
Ending Balance (in shares) at Jun. 30, 2023		207
Total Seagate Technology plc Shareholders' Equity, Ending Balance at Jun. 30, 2023	$ (1,199)	$ 0	7,373	98	(8,670)
Increase (Decrease) in Stockholders' Equity
Common stock, dividends, per share, declared (in dollars per share)	$ 2,800,000
Net income (loss)	$ 335				335
Other comprehensive loss	(100)			(100)
Issuance of ordinary shares under employee stock plans (in shares)		4
Issuance of ordinary shares under employee stock plans	66		66
Capped calls related to the issuance of exchangeable notes	$ (95)		(95)
Tax withholding related to vesting of restricted stock units (in shares)	(1)	(1)
Tax withholding related to vesting of restricted share units	$ (38)				(38)
Dividends to shareholders	(587)				(587)
Share-based compensation	127		127
Ending Balance (in shares) at Jun. 28, 2024		210
Total Seagate Technology plc Shareholders' Equity, Ending Balance at Jun. 28, 2024	$ (1,491)	$ 0	$ 7,471	$ (2)	$ (8,960)
Increase (Decrease) in Stockholders' Equity
Common stock, dividends, per share, declared (in dollars per share)	$ 2,800,000

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Jun. 28, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Organization Seagate Technology Holdings plc (“STX”) and its subsidiaries (collectively, unless the context otherwise indicates, the “Company”) is a leading provider of data storage technology and infrastructure solutions. Its principal products are hard disk drives, commonly referred to as disk drives, hard drives or HDDs. In addition to HDDs, the Company produces a broad range of data storage products including solid state drives (“SSDs”) and storage subsystems and offers storage solutions such as a scalable edge-to-cloud mass data platform that includes data transfer shuttles and a storage-as-a-service cloud. In January 2024, the Company established Singapore as its principal executive offices to better align its operational footprint. Basis of Presentation and Consolidation The Company’s Consolidated Financial Statements include the accounts of the Company and all its wholly-owned and majority-owned subsidiaries, after elimination of intercompany transactions and balances. The preparation of financial statements in accordance with the United States (“U.S.”) generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Financial Statements and accompanying notes. Actual results could differ materially from those estimates. The methods, estimates and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results the Company reports in its Consolidated Financial Statements. Fiscal Year The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. Fiscal years 2024, 2023 and 2022 are comprised of 52 weeks and ended on June 28, 2024, June 30, 2023 and July 1, 2022, respectively. All references to years in these Notes to Consolidated Financial Statements represent fiscal years unless otherwise noted. Fiscal year 2026 will be comprised of 53 weeks and will end on July 3, 2026. Summary of Significant Accounting Policies Cash and Cash Equivalents. The Company considers all highly liquid investments with a remaining maturity of 90 days or less at the time of purchase to be cash equivalents. The Company’s highly liquid investments are primarily comprised of money market funds, time deposits and certificates of deposits. Restricted Cash and Cash Equivalents. Restricted cash and cash equivalents represent cash and cash equivalents held as collateral at banks for various performance obligations. Allowance for expected credit loss. The Company maintains an allowance for expected credit loss relating to its accounts receivable based upon expected collectability. This reserve is established based upon historical trends, global macroeconomic conditions, reasonable and supportable forecasts of future conditions and an analysis of specific exposures. The provision for expected credit loss is recorded as a charge to Marketing and administrative expense in the Company’s Consolidated Statements of Operations. Inventories. Inventories are valued at the lower of cost (using the first-in, first-out method) and net realizable value. Net realizable value is based upon the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Adjustments to reduce cost of inventories to its net realizable value are made, if required, for estimated excess or obsolescence determined primarily by future demand forecasts. Property, Equipment and Leasehold Improvements. Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Equipment and buildings are depreciated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated life of the asset or the remaining term of the lease. The costs of additions and substantial improvements to property, equipment and leasehold improvements, which extend the economic life of the underlying assets, are capitalized. The cost of maintenance and repairs to property, equipment and leasehold improvements is expensed as incurred. In accordance with its policy, the Company reviews the estimated useful lives of its fixed assets on an ongoing basis. Effective from the first quarter of fiscal year 2024, the Company changed the useful lives of certain manufacturing equipment from a range of three three effect of this change in estimate increased the net incom e by $99 million and increased the diluted earnings per share by $0.47 for th e fiscal year ended June 28, 2024 . Goodwill. The Company performs a qualitative assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in the overall industry that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill. If it is determined in the qualitative assessment that the fair value of a reporting unit is more likely than not below its carrying amount, including goodwill, then the Company will perform a quantitative impairment test. The quantitative goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Any excess in the carrying value of a reporting unit over its fair value is recognized as an impairment loss, limited to the total amount of goodwill allocated to that reporting unit. Other Long-lived Assets. The Company tests other long-lived assets, including property, equipment and leasehold improvements and other intangible assets subject to amortization, for recoverability whenever events or changes in circumstances indicate that the carrying value of those assets may not be recoverable. The Company performs a recoverability test to assess the recoverability of an asset group. If the recoverability test indicates that the carrying value of the asset group is not recoverable, the Company will estimate the fair value of the asset group and the excess of the carrying value over the fair value is allocated pro rata to derive the adjusted carrying value of assets in the asset group. Assets Held for Sale. The Company classifies its long-lived assets to be sold as held for sale in the period (i) it has approved and committed to a plan to sell the asset, (ii) the asset is available for immediate sale in its present condition, (iii) an active program to locate a buyer and other actions required to sell the asset have been initiated, (iv) the sale of the asset is probable, (v) the asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. The Company initially measures a long-lived asset that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset until the date of sale. Upon designation as an asset held for sale, the Company stops recording depreciation expense on the asset. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale. Leases. The Company determines if an arrangement is a lease or contains a lease at inception. Right-of-use (“ROU”) assets are included in Other assets, net and lease liabilities are included in Accrued expenses and Other non-current liabilities in the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and the corresponding lease liabilities represent its obligation to make lease payments arising from the lease. The Company combines lease and non-lease components for facility leases and does not recognize ROU assets and lease liabilities for leases with an initial term of 12 months or less on the Consolidated Balance Sheets. Lease liabilities are measured at the present value of the remaining lease payments and ROU assets are based on the lease liability, adjusted for lease prepayments, lease incentives received and the lessee’s initial direct costs. For the Company’s leases that do not provide an implicit rate, the net present value of future minimum lease payments is determined using the Company’s estimated incremental borrowing rate based on the information available at the lease commencement date. Additionally, the Company’s lease term may include options to extend or terminate the lease. These options are reflected in the ROU asset and lease liability when it is reasonably certain that the Company will exercise the option. The Company’s lease agreements do not contain any material residual value guarantees. The Company recognizes lease expense on a straight-line basis over the lease term. Variable lease payments not dependent on an index or a rate primarily consist of common area maintenance charges, are expensed as incurred, and are not included in the ROU asset and lease liability calculation. Derivative Financial Instruments. The Company records all derivatives on the balance sheet at fair value and establishes criteria for designation and effectiveness of hedging relationships. Foreign currency forward exchange contracts are used to economically hedge the foreign currency exposure on forecasted expenditures in currencies other than U.S. dollar. The Company also enters into foreign currency forward contracts with contractual maturities of less than one month, which are designed to mitigate the effect of changes in foreign exchange rates on monetary assets and liabilities. The Company determines the fair value of these instruments by considering the estimated amount it would pay or receive to terminate these agreements at the reporting date. The changes in the fair value of highly effective designated cash flow hedges are recorded in Accumulated Other Comprehensive Income (“AOCI”) until the hedged item is recognized in earnings. The Company excludes the change in forward points from the assessment of hedge effectiveness and recognizes the excluded component in Other, net in the Consolidated Statements of Operations. The Company de-designates its cash flow hedges when the forecasted hedged transactions affect earnings or it is probable the forecasted hedged transactions will not occur in the initially identified time period. At such time, the associated gains and losses deferred in AOCI on the Company’s Consolidated Balance Sheets are reclassified into earnings and any subsequent changes in the fair value of such derivative instruments are immediately reflected in earnings. The Company recognizes the unrealized gains and losses due to the changes in the fair value of derivatives that are not designated as hedging instruments or are not assessed to be highly effective in Other, net in the Consolidated Statements of Operations. The Company recognizes gains and losses from foreign currency forward exchange contracts within Other non-cash operating activities in the Consolidated Statements of Cash Flows. Warranty. The Company estimates probable product warranty costs at the time revenue is recognized. The Company generally provides warranty on its products for a period of 1 to 5 years. The Company's warranty provision considers estimated product failure rates, trends (including the timing of product returns during the warranty periods), and estimated repair or replacement costs related to product quality issues, if any. The Company also exercises judgment in estimating its ability to sell refurbished products. Revenue Recognition and Sales Incentive Programs. The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue from sales of products is generally recognized upon transfer of control to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products, net of sales taxes. This typically occurs upon shipment from the Company. When applicable, the Company includes shipping charges billed to customers in Revenue and includes the related shipping costs in Cost of revenue on the Company's Consolidated Statements of Operations. The Company records estimated variable consideration at the time of revenue recognition as a reduction to revenue. Variable consideration generally consists of sales incentive programs, such as price protection and volume incentives aimed at increasing customer demand. For original equipment manufacturers (“OEMs”) sales, rebates are typically established by estimating the most likely amount of consideration expected to be received based on an OEM customer’s volume of purchases from the Company or other agreed upon rebate programs. For the distribution and retail channel, these programs typically involve estimating the most likely amount of rebates related to a customer’s level of sales, order size, advertising or point of sale activity as well as the expected value of price protection adjustments based on historical analysis and forecasted pricing environment. Marketing development program costs are accrued and recorded as a reduction to revenue at the same time that the related revenue is recognized. At the end of the reporting period, the Company has unfulfilled product purchase orders which represent performance obligations not delivered, or partially undelivered under existing customer contracts. Some of these purchase orders are non-cancellable in nature. As of June 28, 2024, all non-cancellable purchase orders are less than one year in duration and are expected to be fulfilled in the next twelve months. The Company applied optional exemption to not disclose the value of these remaining performance obligations as they are part of a contract that has an original expected duration of one year or less. The Company expenses sales commissions as incurred because the amortization period would have been one year or less. These costs are recorded as Marketing and administrative in the Company’s Consolidated Statements of Operations. Restructuring Costs. The Company incurs restructuring costs in connection with workforce reductions, consolidation or closure of facilities and other exit costs. The Company records employee termination liabilities when it is probable that benefits will be paid and the amount is reasonably estimable. The rates used in determining severance accruals are based on existing plans, historical experiences and negotiated settlements. Other costs associated with a restructuring plan or exit or disposal activities are recognized in the period in which the liability is incurred or the asset is impaired. Advertising Expense. The cost of advertising is expensed as incurred. Advertising costs were approximately $18 million , $30 million and $34 million in fiscal years 2024, 2023 and 2022, respectively. Share-Based Compensation. The Company accounts for share-based compensation at fair value, net of estimated forfeitures. When estimating forfeitures, the Company considers voluntary termination behavior as well as the historical analysis of actual forfeited awards. The Company estimates the fair value of granted share options, restricted share units (“RSUs”), and performance-based share units (“PSUs”) subject to a performance goal related to the Company’s adjusted earnings per share using the Black-Scholes-Merton valuation model and a single share award approach. The Company estimates the fair value of PSUs related to the Company’s return on invested capital and total shareholder return using a Monte Carlo simulation valuation model. Share-based compensation expense for share options and RSUs with only a service condition is recognized on a straight-line basis over the requisite service period. The expense for PSUs with both a service condition and a performance or market condition is recognized on a graded vesting basis. Accounting for Income Taxes . The Company records a provision or benefit for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of the enactment. The Company periodically reassesses the need for valuation allowances on the deferred tax assets, considering both positive and negative evidence to evaluate whether it is more likely than not that all or a portion of such assets will not be realized. The Company recognizes a tax benefit only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Equity Investments. From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under equity method or the measurement alternative. These investments are included in Other assets, net in the Company's Consolidated Balance Sheets and are subsequently adjusted through Other, net in the Consolidated Statements of Operations. Investments are accounted for under the equity method if the Company has the ability to exercise significant influence, but does not have a controlling financial interest. These investments are measured at cost, less any impairment plus the Company's portion of investee’s income or loss. The Company uses the financial statements of investees to determine any adjustments, which are received on a one-quarter lag. For equity investments where the Company does not have the ability to exercise significant influence and there are no readily determinable fair values, the Company has elected to apply the measurement alternative, under which investments are measured at cost, less impairment, and adjusted for qualifying observable price changes on a prospective basis. The Company’s strategic investments are periodically analyzed to determine whether or not there are indicators of impairment by assessing factors such as deterioration of earnings, adverse change in market/industry conditions, the ability to operate as a going concern, and other factors which indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Consolidated Statements of Operations. Foreign Currency Remeasurement and Translation. The U.S. dollar is the functional currency for the majority of the Company's foreign operations. Monetary assets and liabilities denominated in foreign currencies are remeasured into the functional currency at the balance sheet date at exchange rates in effect at the end of each period. The gains and losses from the remeasurement are included in Other, net in the Company's Consolidated Statements of Operations. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized in foreign currency translation included in Accumulated other comprehensive income, which is a component of Shareholders’ Deficit. Government Incentives. The Company enters into government incentive arrangements with domestic and foreign, local, regional and national governments, which vary in size, duration and conditions. In fiscal year 2024, approximately $3 million of operating grants were recognized as reductions to Cost of revenue $17 million , which were reflected within Accrued expenses in the Company's Consolidated Balance Sheets. In fiscal year 2023, approximately $13 million of operating grants were recognized as reductions to Cost of revenue Use of Estimates The preparation of financial statements requires management to make estimates, judgments and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Estimates are assessed each period and updated to reflect current information, including those related to revenue recognition, share-based compensation, restructuring accruals, provision for taxes, valuation allowance for deferred taxes, provision for expected credit losses, inventory reserves, warranty accruals, and impairment assessments of goodwill, intangible assets and other long-lived assets. The Company believes that these estimates, judgments and assumptions are reasonable under the circumstances, and are subject to significant uncertainties, some of which are beyond the Company's control. Should any of these estimates change, it could adversely affect the Company's results of operations. Actual results could differ materially from these estimates under different assumptions or conditions. Concentrations Concentration of Credit Risk. The Company’s customer base is concentrated with a small number of customers. The Company does not generally require collateral or other security to support accounts receivable. To reduce credit risk, the Company performs ongoing credit evaluations on its customers’ financial condition. The Company establishes allowances for expected credit losses based upon factors surrounding the credit risk of customers, global macroeconomic conditions and an analysis of specific exposures. One customer and two customers accounted for more than 10% of the Company’s accounts receivable as of June 28, 2024 and June 30, 2023, respectively . Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and foreign currency forward exchange contracts. The Company maintains the cash and cash equivalents with four major financial institutions and a portion of such balances exceed or are not subject to Federal Deposit Insurance Corporation, or FDIC, insurance limits. The Company mitigates concentrations of credit risk in its financial instruments through diversification, by investing in highly-rated securities and/or major multinational companies. In entering into foreign currency forward exchange contracts, the Company assumes the risk that might arise from the possible inability of counterparties to meet the terms of their contracts. The counterparties to these contracts are major multinational commercial and investment banks, and the Company has not incurred and does not expect any losses as a result of counterparty defaults. Supplier Concentration. Certain of the raw materials, components and equipment used by the Company in the manufacture of its products are available from single-sourced direct and indirect vendors. Shortages could occur in these essential materials and components due to an interruption of supply or increased demand in the industry. If the Company were unable to procure certain materials, components or equipment at all or acceptable prices, it would be required to reduce its manufacturing operations, which could have a material adverse effect on its results of operations. Recently Adopted Accounting Pronouncements In September 2022, the Financial Accounting Standards Board (FASB) issued ASU 2022-04 (ASC Subtopic 405-50), Disclosure of Supplier Finance Program Obligations. This ASU requires disclosure of key terms of the outstanding supplier finance programs and a roll forward of the related obligations. The Company adopted this guidance during the first quarter of fiscal year 2024, except for the disclosure on rollforward information which will be adopted in fiscal year 2025, in line with the effective adoption date prescribed by the FASB. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements. Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07 (ASC Topic 280), Improvements to Reportable Segment Disclosures . This ASU improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. This standard is expected to impact the Company’s disclosures and will not have impact on its Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09 (ASC Topic 740), Improvements to Income Tax Disclosures

Balance Sheet Information

Balance Sheet Information	12 Months Ended
	Jun. 28, 2024
Disclosure Text Block Supplement [Abstract]
Balance Sheet Information	Balance Sheet Information Cash, Cash Equivalents and Restricted Cash The following table provides a summary of cash, cash equivalents and restricted cash reported within the Company’s Consolidated Balance Sheets that reconciles to the corresponding amount in the Company’s Consolidated Statements of Cash Flows: (Dollars in millions) June 28, June 30, July 1, Cash and cash equivalents $ 1,358 $ 786 $ 615 Restricted cash included in Other current assets 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 1,360 $ 788 $ 617 Accounts Receivable, net The details of the accounts receivable, net were as follows: (Dollars in millions) June 28, June 30, Accounts receivable $ 433 $ 625 Allowances for expected credit losses (4) (4) Account receivable, net $ 429 $ 621 Activity in the expected credit losses accounts was as follows: (Dollars in millions) Balance at Beginning of Period Charges (Credit) to Operations Balance at End of Period Fiscal year ended July 1, 2022 $ 4 — $ 4 Fiscal year ended June 30, 2023 $ 4 — $ 4 Fiscal year ended June 28, 2024 $ 4 — $ 4 In connection with the Company’s factoring agreements, from time to time the Company sells accounts receivables to third parties for cash proceeds less a discount. During fiscal year 2024, the Company sold trade receivables without recourse for cash proceeds o f $1.2 billion, of which $294 million re mained subject to servicing by the Company as of June 28, 2024. During fiscal year 2023, the Company sold trade receivables without recourse for cash proceeds of $876 million, of which $275 million remained subject to servicing by the Company as of June 30, 2023. The discounts on trade receivables sold were $11 million for fiscal year 2024, $11 million for fiscal year 2023 and immaterial for fiscal year 2022, respectively. Inventories, net The details of the inventory, net were as follows: (Dollars in millions) June 28, June 30, Raw materials and components $ 270 $ 241 Work-in-process 831 682 Finished goods 138 217 Total inventories, net $ 1,239 $ 1,140 Other Current Assets The details of the other current assets were as follows: (Dollars in millions) June 28, June 30, Vendor receivables $ 110 $ 167 Other current assets 196 191 Total $ 306 $ 358 Property, Equipment and Leasehold Improvements, net The components of property, equipment and leasehold improvements, net were as follows: (Dollars in millions) Useful Life in Years June 28, June 30, Land and land improvements $ 18 $ 21 Equipment 3 – 10 8,632 8,504 Buildings and leasehold improvements Up to 30 1,412 1,435 Construction in progress 198 307 Gross property, equipment and leasehold improvements 10,260 10,267 Less: accumulated depreciation and amortization (8,646) (8,561) Property, equipment and leasehold improvements, net $ 1,614 $ 1,706 Depreciation expense, which includes amortization of leasehold improvements, was $264 million , $504 million and $431 million for fiscal years 2024, 2023 and 2022, respectively. In fiscal year 2024, the Company recognized a charge of $13 million for the accelerated depreciation of certain fixed assets which was recorded to Cost of revenue in the Consolidated Statements of Operations. In fiscal year 2023, the Company recognized a charge of $85 million for the accelerated depreciation of certain fixed assets, of which $60 million and $25 million was recorded to Cost of revenue and Product development, respectively, in the Consolidated Statements of Operations. In fiscal year 2022, the accelerated depreciation charge recogniz ed was immaterial. Interest on borrowings related to eligible capital expenditures is capitalized as part of the cost of the qualified assets and amortized over the estimated useful lives of the assets. During fiscal years 2024, 2023 and 2022, the Company capitalized interest of $9 million , $8 million and $3 million, respectively. Accrued Expenses The details of the accrued expenses were as follows: (Dollars in millions) June 28, June 30, Dividends payable $ 147 $ 145 Other accrued expenses 507 603 Total $ 654 $ 748 Accumulated Other Comprehensive (Loss) Income (“AOCI”) The components of AOCI, net of tax, were as follows: (Dollars in millions) Unrealized Gains/(Losses) on Cash Flow Hedges Unrealized Gains/(Losses) on Post-Retirement Plans Foreign Currency Translation Adjustments Total Balance at July 1, 2022 $ 51 $ (14) $ (1) $ 36 Other comprehensive income before reclassifications 65 11 — 76 Amounts reclassified from AOCI (13) (1) — (14) Other comprehensive income 52 10 — 62 Balance at June 30, 2023 103 (4) (1) 98 Other comprehensive (loss) income before reclassifications (13) 1 1 (11) Amounts reclassified from AOCI (90) 1 — (89) Other comprehensive (loss) income (103) 2 1 (100) Balance at June 28, 2024 $ — $ (2) $ — $ (2)

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Jun. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The carrying amount of goodwill was $1.2 billion as of June 28, 2024 and June 30, 2023. Goodwill divested as a result of the sale of SoC business during fiscal year 2 024 was $18 million. Refe r to Note 18. Divestiture for more information. There were no other additions to, disposals of, impairments of or translation adjustments to goodwill in fiscal years 2024, 2023 and 2022. Other Intangible Assets Other intangible assets consist primarily of existing technology, customer relationships and trade names acquired in business combinations. Intangibles are amortized on a straight-line basis over the respective estimated useful lives of the assets. Amortization is charged to Operating expenses in the Consolidated Statements of Operations. In fiscal year 2024, there was no amortization expense for other intangible assets. For fiscal years 2023 and 2022, amortization expense for other intangible assets was $9 million and $20 million, respectively. There was no net carrying value of other intangible assets subject to amortization as of June 28, 2024 and June 30, 2023.

Debt

Debt	12 Months Ended
	Jun. 28, 2024
Debt Disclosure [Abstract]
Debt	Debt The following table provides details of the Company’s debt as of June 28, 2024 and June 30, 2023: (Dollars in millions) June 28, June 30, Unsecured Senior Notes (1) $1,000 issued on May 28, 2014 at 4.75% due January 1, 2025 (the “2025 Notes”) , interest payable semi-annually on January 1 and July 1 of each year. 479 479 $700 issued on May 14, 2015 at 4.875% due June 1, 2027 (the “2027 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 505 504 $500 issued on June 18, 2020 at 4.091% due June 1, 2029 (the “June 2029 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 471 465 $500 issued on December 8, 2020 at 3.125% due July 15, 2029 (the “July 2029 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 163 163 $500 issued on May 30, 2023 at 8.25% due December 15, 2029 ( the “December 2029 Notes” ), interest payable semi-annually on June 15 and December 15 of each year. 500 500 $500 issued on June 10, 2020 at 4.125% due January 15, 2031 (the “January 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 275 275 $500 issued on December 8, 2020 at 3.375% due July 15, 2031 (the “July 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 72 72 $500 issued on May 30, 2023 at 8.50% due July 15, 2031 ( the “8.50% July 2031 Notes” ), interest payable semi-annually on January 15 and July 15 of each year. 500 500 $750 issued on November 30, 2022 at 9.625% due December 1, 2032 (the “2032 Notes”), interest payable semi-annually on June 1 and December 1 of each year. 750 750 $500 issued on December 2, 2014 at 5.75% due December 1, 2034 (the “2034 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 489 489 Exchangeable Senior Notes (1) $1,500 issued on September 13, 2023 at 3.50% due June 1, 2028 ( the “2028 Notes” ), interest payable semi-annually on March 1 and September 1 of each year. 1,500 — Term Loans $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.125% to 2.375%, ( the “Term Loan A1”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of September 16, 2025. — 430 $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A2”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. — 430 $600 borrowed on August 18, 2022 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A3 ”), repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. — 430 5,704 5,487 Less: unamortized debt issuance costs (30) (36) Debt, net of debt issuance costs 5,674 5,451 Less: current portion of long-term debt (479) (63) Long-term debt, less current portion $ 5,195 $ 5,388 ___________________________________ (1 ) All unsecured senior notes and exchangeable senior notes are issued by Seagate HDD Cayman (“Seagate HDD”), and the obligations under these notes are fully and unconditionally guaranteed, on a senior unsecured basis, by Seagate Technology Unlimited Company (“STUC”) and STX. 2028 Exchangeable Senior Notes and related Capped Call Transactions 2028 Notes. On September 13, 2023, Seagate HDD, in a private placement, issued $1.5 billion in aggregate principal amount of 3.50% Exchangeable Senior Notes due 2028 (the “2028 Notes”), which includes $200 million aggregate principal amount pursuant to the over-allotment option of the initial purchasers to purchase additional notes. The 2028 Notes will mature on June 1, 2028, with interest payable semi-annually on March 1 and September 1 of each year, commencing March 1, 2024. For the fiscal year ended June 28, 2024, the effective interest rate for the 2028 Notes was 3.94%, with contractual interest expense of $25 million and immaterial amortization of debt issuance costs. The entire outstanding principal amount of Term Loans A1, A2 and A3 were repaid from the proceeds of the 2028 Notes issuance. The exchange was accounted for as a debt extinguishment and the Company recorded a net los s of $29 million, which was included in the Net (loss) gain recognized from early redemption of debt in the Company’s Consolidated Statements of Operations . In connection with the repayment of Term Loans, the Company terminated certain interest rate swap agreements. Refer to “ Note 8. Derivative Financial Instruments ” for more details. Prior to March 1, 2028, the 2028 Notes are exchangeable at the option of the holders only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ending on December 31, 2023 (and only during such calendar quarter), if the last reported sale price of the ordinary Shares for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the exchange price in effect on each applicable trading day; • during the five business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of 2028 Notes for each trading day period was less than 98% of the product of the last reported sale price of the ordinary shares and the applicable exchange rate on such trading day; or • upon the occurrence of specified corporate events described in the indenture with respect to the 2028 Notes. On or after March 1, 2028, the 2028 Notes are exchangeable at any time at the option of the holders until the close of business on the second scheduled trading day immediately preceding the maturity date, unless the 2028 Notes have been previously redeemed or repurchased by Seagate HDD. Upon exchange of the 2028 Notes, Seagate HDD will pay cash up to the aggregate principal amount of 2028 Notes to be exchanged and will pay or cause to be delivered, as the case may be, cash, ordinary shares of the Company or a combination of cash and ordinary shares of the Company, at Seagate HDD’s election, in respect of any remainder of the exchange obligation in excess of such principal amount. The initial exchange rate for the 2028 Notes is 12.1253 ordinary shares per $1,000 principal amount of 2028 Notes. Seagate HDD may redeem the 2028 Notes at its option, in whole but not in part, if Seagate HDD or the Guarantors have, or on the next interest payment date would, become obligated to pay to the holder of any Note additional amounts as a result of certain tax-related events at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest, including additional interest, if any, to, but excluding, the redemption date; provided that Seagate HDD may only redeem the 2028 Notes if: (x) Seagate HDD or the relevant Guarantor cannot avoid these obligations by taking commercially reasonable measures available to Seagate HDD or such Guarantor; and (y) Seagate HDD delivers to the Trustee an opinion of outside legal counsel of recognized standing in the relevant taxing jurisdiction attesting to such tax-related event and obligation to pay additional amounts. Seagate HDD also may redeem the 2028 Notes at its option on or after September 8, 2026, in whole or in part, if the last reported sale price of ordinary shares of the Company has been at least 130% of the exchange price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which Seagate HDD provides notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Seagate HDD provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If Seagate HDD redeems less than all the outstanding 2028 Notes, at least $150 million aggregate principal amount of 2028 Notes must be outstanding and not subject to redemption as of the relevant notice of redemption date. As of June 28, 2024, the 2028 Notes were not exchangeable. Refer to “ Note 13. Net Income (Loss) Per Share ” for the potential dilutive impact of the 2028 Notes. In connection with the 2028 Notes, the Company and Seagate HDD entered into privately negotiated capped call transactions with certain financial institutions. The cap price of the capped call transactions will initially be $107.848 per share. The cost of the capped call transactions was $95 million, which met certain accounting criteria to be accounted under Additional Paid-in Capital as part of the Shareholders’ Deficit and are not accounted as derivatives in the Company’s Consolidated Balance Sheets. Credit Agreement The credit agreement dated as of February 20, 2019, by and among, Seagate Technology Holdings plc, Seagate HDD, The Bank of Nova Scotia, as administrative agent, and the lenders party thereto (as amended from time to time, the “Credit Agreement”) includes two financial covenants: (1) interest coverage ratio and (2) total net leverage ratio. For the fiscal quarter ended June 28, 2024 until the end of the covenant relief period, which terminates on June 27, 2025, the maximum permitted total net leverage ratio is 6.75 to 1.00, and applies only to the extent that the aggregate outstanding amount of revolving loans, swing line loans and the aggregate face amount of certain letters of credit exceeds 25% of the then outstanding revolving commitments in effect (the “Testing Condition”) as of the last day of the fiscal quarter. The maximum permitted total leverage ratio for each fiscal quarter ending after June 27, 2025 is 4.00 to 1.00. For the fiscal quarter ended June 28, 2024 until the fiscal quarter ending June 27, 2025, the minimum interest coverage ratio is 2.25 to 1.00, and applies only to the extent that the Testing Condition is satisfied as of the last day of the fiscal quarter. The minimum interest coverage ratio is 3.25 to 1.00 for each fiscal quarter ending after June 27, 2025. Future Principal Payments on Long-term Debt At June 28, 2024, future principal payments on long-term debt were as follows (in millions): Fiscal Year Amount 2025 $ 479 2026 — 2027 505 2028 1,500 2029 495 Thereafter 2,750 Total $ 5,729

Income Taxes

Income Taxes	12 Months Ended
	Jun. 28, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income (loss) before income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, U.S. $ 249 $ 300 $ 145 Non-U.S. 196 (796) 1,534 $ 445 $ (496) $ 1,679 The provision for income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Current income tax expense: U.S. $ 2 $ 6 $ 4 Non-U.S. 30 17 35 Total Current 32 23 39 Deferred income tax expense/(benefit): U.S. 71 9 3 Non-U.S. 7 1 (12) Total Deferred 78 10 (9) Provision for income taxes $ 110 $ 33 $ 30 The significant components of the Company’s deferred tax assets and liabilities were as follows: Fiscal Years Ended (Dollars in millions) June 28, June 30, Deferred tax assets Accrued warranty $ 37 $ 38 Inventory carrying value adjustments 32 40 Receivable allowances 9 11 Accrued compensation and benefits 36 43 Capitalized research expenses — 119 Depreciation 19 40 Restructuring accruals 2 14 Lease liabilities 64 62 Other accruals and deferred items 11 14 Net operating losses 613 542 Tax credit carryforwards 593 619 Capital loss carryforwards 67 — Other assets 40 1 Gross: Deferred tax assets 1,523 1,543 Less: Valuation allowance (430) (370) Net: Deferred tax assets 1,093 1,173 Deferred tax liabilities Unremitted earnings of certain non-U.S. entities (4) (4) Acquisition-related items (1) (1) Right-of-use assets (63) (62) Other liabilities — (2) Net: Deferred tax liabilities (68) (69) Total net deferred tax assets $ 1,025 $ 1,104 At June 28, 2024, the Company recorded $1.0 billion of net deferred tax assets. The realization of most of these deferred tax assets is primarily dependent on the Company’s ability to generate sufficient U.S. and certain non-U.S. taxable income in future periods. Although realization is not assured, the Company’s management believes it is more likely than not that these deferred tax assets will be realized. The amount of deferred tax assets considered realizable, however, may increase or decrease in subsequent periods when the Company re-evaluates the underlying basis for its estimates of future U.S. and certain non-U.S. taxable income. The deferred tax asset valuation allowance increased by $60 million in fiscal year 2024, which primarily relates to the generation of capital loss carryforwards which are not likely to be realized. At June 28, 2024, the Company had U.S. tax net operating loss and credit carryforwards of approximately $3.7 billion and $709 million, respectively, of which approximately $4 million and $22 million, respectively, are scheduled to expire at various dates in fiscal year 2025, if not utilized. At June 28, 2024, the Company had non-U.S. tax net operating loss carryforwards of approximately $411 million, all of which are indefinite lived. As of June 28, 2024, the Company had gross capital loss carryforwards of $294 million, which if not utilized, will expire as of fiscal year 2029. As of June 28, 2024, approximately $17 million and $18 million of the Company’s total U.S. net operating loss and tax credit carryforwards, respectively, are subject to annual limitations due to the ownership change limitations provided by the Internal Revenue Code. We established Singapore as our principal executive offices in fiscal year 2024. The Singaporean statutory tax rate of 17% is used for purposes of the reconciliation between the provision for income taxes at the statutory rate and our effective tax rate. For fiscal years 2023 and 2022, a notional Irish statutory rate of 25% was used. Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Provision (benefit) at statutory rate $ 76 $ (124) $ 420 Permanent differences 5 8 5 Valuation allowance 47 (18) 7 Effect of rates different than statutory (2) 178 (371) Research credit (9) (18) (26) Capital loss carryforward (11) — — Other individually immaterial items 4 7 (5) Provision for income taxes $ 110 $ 33 $ 30 A substantial portion of the Company's operations in Singapore and Thailand operate under various tax incentive programs, which expire in whole or in part at various dates through fiscal year 2036. Certain tax incentives may be extended if specific conditions are met. The net impact of these tax incentive programs was to increase the Company’s net income by approximately $40 million in fiscal year 2024 ($0.19 per share, diluted), to decrease the Company's net loss by approximately $14 million in fiscal year 2023 ($0.07 per share, basic) and to increase the Company’s net income by approximately $290 million in fiscal year 2022 ($1.29 per share, diluted). The Company analyzes the potential needs for deferred tax liabilities with respect to the accumulated earnings of foreign subsidiaries annually. The analysis focuses on the outside basis differences in the stock of the foreign subsidiaries as well as the withholding tax obligations those subsidiaries may have with respect to any distribution. The undistributed earnings for which taxes are not provided are permanently reinvested or can be repatriated without incremental tax liability. As of June 28, 2024 and June 30, 2023, the Company had approximately $112 million and $116 million, respectively, of unrecognized tax benefits excluding interest and penalties. These amounts, if recognized, would impact the effective tax rate subject to certain future valuation allowance offsets. The following table summarizes the activities related to the Company’s gross unrecognized tax benefits: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Balance of unrecognized tax benefits at the beginning of the year $ 116 $ 114 $ 108 Gross increase for tax positions of prior years 3 — 1 Gross decrease for tax positions of prior years (12) (4) (1) Gross increase for tax positions of current year 5 7 6 Gross decrease for tax positions of current year — (1) — Balance of unrecognized tax benefits at the end of the year $ 112 $ 116 $ 114 It is the Company’s policy to include interest and penalties related to unrecognized tax benefits in the provision for income taxes in the Consolidated Statements of Operations. Interest and penalties recorded on these tax positions were not material to any periods presented in the Consolidated Statements of Operations. As of June 28, 2024, accrued interest and penalties related to unrecognized tax benefits did not materially change compared to fiscal year 2023. During the 12 months beginning June 29, 2024, the Company does not expect a material change to its unrecognized tax benefits as a result of the expiration of certain statutes of limitation.

Leases, Codification Topic 842

Leases, Codification Topic 842	12 Months Ended
	Jun. 28, 2024
Leases [Abstract]
Lessee, Operating Leases	Leases The Company is a lessee in several operating leases related to real estate facilities for warehouse, office and lab space. The Company’s lease arrangements comprise operating leases with various expiration dates through 2068. The lease term includes the non-cancelable period of the lease, adjusted for options to extend or terminate the lease when it is reasonably certain that an option will be exercised. During fiscal years 2024 and 2023, the Company sold and leased back certain properties and recorded a net gain of $30 million and $156 million respectively, within Restructuring and other, net in the Consolidated Statements of Operations. Operating lease costs include short-term lease costs and are shown net of immaterial sublease income. The components of lease costs and other information related to leases were as follows: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Operating lease cost $ 72 $ 21 $ 16 Variable lease cost 3 3 4 Total lease cost $ 75 $ 24 $ 20 Operating cash outflows from operating leases $ 63 $ 23 $ 20 During fiscal years 2024 and 2023, the Company obtained $47 million and $353 million ROU assets in exchange for new operating lease liabilities, respectively. In fiscal year 2022, the ROU assets obtained in exchange for new operating lease liabilities were immaterial. June 28, June 30, July 1, Weighted-average remaining lease term 8.6 years 9.6 years 9.3 years Weighted-average discount rate 8.45 % 8.49 % 6.40 % ROU assets and lease liabilities included in the Company’s Consolidated Balance Sheets were as follows: (Dollars in millions) Balance Sheet Location June 28, June 30, ROU assets Other assets, net $ 403 $ 396 Current lease liabilities Accrued expenses 61 51 Non-current lease liabilities Other non-current liabilities 338 333 At June 28, 2024, future lease payments included in the measurement of lease liabilities were as follows (in millions): Fiscal Year Amount 2025 $ 63 2026 64 2027 59 2028 60 2029 62 Thereafter 256 Total lease payments 564 Less: imputed interest (165) Present value of lease liabilities $ 399

Restructuring and Exit Costs

Restructuring and Exit Costs	12 Months Ended
	Jun. 28, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Exit Costs	Restructuring and Other, Net During fiscal years 2024, 2023 and 2022, the Company recorded restructuring and other, net benefit of $30 million, and charge of $102 million and $3 million, respectively, in the Company’s Consolidated Statements of Operations. The net benefit for fiscal year 2024 was primarily due to the net gain of $30 million from the sale and leaseback of certain property. The net proceeds of $34 million from this transaction were recorded as an investing inflow in the Company’s Statements of Cash Flows for the fiscal year 2024. The Company’s restructuring plans are comprised primarily of charges related to workforce reduction costs, including severance and other one-time termination benefits and facilities and other exit costs. The Company’s significant restructuring plans are described below. October 2022 Plan - On October 24, 2022, the Company committed to an October 2022 restructuring plan (the “October 2022 Plan”) to reduce its cost structure to better align the Company’s operational needs to current economic conditions while continuing to support the long-term business strategy. On March 29, 2023, in light of further deteriorating economic conditions, the Company committed to an expansion of the October 2022 Plan. This expanded plan included aligning its business plan to near-term market conditions, along with other cost saving measures. The October 2022 Plan was substantially completed by the end of fiscal year 2023. April 2023 Plan - On April 20, 2023, the Company committed to an April 2023 restructuring plan (the “April 2023 Plan”) to further reduce its cost structure in response to changes in macroeconomic and business conditions. The April 2023 Plan was intended to align the Company’s operational needs with the near-term demand environment while continuing to support the long-term business strategy. The April 2023 Plan was substantially completed by the end of fiscal year 2023. The following table summarizes the Company’s restructuring activities under its active restructuring plans for fiscal years 2024, 2023 and 2022: April 2023 Plan October 2022 Plan Other Plans (Dollars in millions) Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Total Accrual Balance at July 2, 2021 $ — $ — $ — $ — $ 2 $ 6 $ 8 Restructuring charges — — — — 2 1 3 Cash payments — — — — (4) (2) (6) Accrual Balance at July 1, 2022 — — — — — 5 5 Restructuring charges 145 3 104 7 10 — 269 Cash payments (37) (3) (103) (1) (10) (1) (155) Adjustments — — — (1) 1 — — Accrual Balance at June 30, 2023 108 — 1 5 1 4 119 Restructuring charges — — — — 6 1 7 Cash payments (106) — (1) (3) (5) (1) (116) Adjustments (1) — — (1) — (4) (6) Accrual Balance at June 28, 2024 $ 1 $ — $ — $ 1 $ 2 $ — $ 4 Total costs incurred to date as of June 28, 2024 $ 144 $ 3 $ 104 $ 5 $ 70 $ 10 $ 336 Total expected costs to be incurred as of June 28, 2024 $ — $ — $ — $ — $ — $ — $ — The accrued restructuring balance of $4 million at June 28, 2024 was included in Accrued expenses in the Company’s Consolidated Balance Sheets. Of the accrued restructuring balance of $119 million at June 30, 2023, $117 million was included in Accrued expenses and $2 million was included in Other non-current liabilities in the Company’s Consolidated Balance Sheets. During fiscal years 2024 and 2023 , the Company sold certain properties and assets and recognized a net gain of $31 million and $167 million, respectively . The net gain was included in Restructuring and other, net in the Company’s Consolidated Statements of Operations.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Jun. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company is exposed to foreign currency exchange rate, interest rate and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements was to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. On September 13, 2023, the Company terminated its then existing interest rate swap agreements as a result of the repayment of Term Loans A1, A2 and A3 and received cash proceeds of $25 million from the counterparty. The cash proceeds are reported within Net cash provided by operating activities in the Company’s Consolidated Statements of Cash Flows during the fiscal year ended 2024. The Company discontinued the related hedge accounting prospectively and realized a net gain of $104 million in Net gain from termination of interest rate swap in the Consolidated Statements of Operations during the fiscal year ended 2024. Additionally, $6 million of the gains were amortized to Interest expense prior to the termination of interest rate swap in the Company’s Consolidated Statements of Operations. Refer to “ Note 4. Debt ” for more details. As of June 28, 2024, the Company does not have any interest rate swap contracts. The net unrealized loss on cash flow hedges was immaterial as of June 28, 2024. The net unrealized gain on cash flow hedges was $12 million as of June 30, 2023. The following tables show the effect of the Company’s derivative instruments in the Consolidated Statements of Comprehensive Income (Loss) and the Consolidated Statements of Operations for the fiscal year ended June 28, 2024. (Dollars in millions) Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Income on Derivatives Amount of Gain/(Loss) Recognized in Income on Derivatives Foreign currency forward exchange contracts Other, net $ (8) Total return swap Operating expenses 10 (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency forward exchange contracts $ 2 Cost of revenue $ (3) Other, net $ 3 Interest rate swap (15) Interest expense (11) Net gain from termination of interest rate swap (1) 104 _____________________________ (1) The net gain recognized into earnings as a result of the discontinuance of interest rate swap during the fiscal year ended June 28, 2024. The following tables show the effect of the Company’s derivative instruments in the Consolidated Statements of Comprehensive Income (Loss) and the Consolidated Statements of Operations for the fiscal year ended June 30, 2023. (Dollars in millions) Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Income on Derivatives Amount of Gain/(Loss) Recognized in Income on Derivatives Foreign currency forward exchange contracts Other, net $ (7) Total return swap Operating expenses 6 (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency forward exchange contracts $ (6) Cost of revenue $ (16) Other, net $ (4) Interest rate swap 71 Interest expense 29 Interest expense — The Company is subject to equity market risks due to changes in the fair value of the notional investments selected by its employees as part of its non-qualified deferred compensation plan: the Seagate Deferred Compensation Plan (the “SDCP”). The Company entered into a Total Return Swap (“TRS”) in order to manage the equity market risks associated with the SDCP’s liabilities. The TRS is designed to substantially offset changes in the SDCP’s liabilities due to changes in the value of the investment options made by employees. The contract, which settles monthly and effectively mitigates counterparty risk will mature in June 2025. The Company did not designate the TRS as a hedge. Rather, the Company records all changes in the fair value of the TRS to earnings to offset the market value changes of the SDCP’s liabilities. The gross notional and fair value of derivative instruments in the Consolidated Balance Sheets as of June 28, 2024 and June 30, 2023 were as follows: As of June 28, 2024 Derivative Assets Derivative Liabilities (Dollars in millions) Outstanding Gross Notional Balance Sheet Fair Value Balance Sheet Fair Value Derivatives designated as hedging instruments: Foreign currency forward exchange contracts $ 35 Other current assets $ — Accrued expenses $ (1) Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts 165 Other current assets 1 Accrued expenses — Total return swap 112 Other current assets — Accrued expenses — Total derivatives $ 312 $ 1 $ (1) As of June 30, 2023 Derivative Assets Derivative Liabilities (Dollars in millions) Outstanding Gross Notional Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedging instruments: Foreign currency forward exchange contracts $ 445 Other current assets $ 2 Accrued expenses $ (10) Interest rate swap 1,288 Other current assets 20 Accrued expenses — Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts 197 Other current assets — Accrued expenses (1) Total return swap 108 Other current assets 1 Accrued expenses — Total derivatives $ 2,038 $ 23 $ (11)

Fair Value

Fair Value	12 Months Ended
	Jun. 28, 2024
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company's own assumptions of market participant valuation (unobservable inputs). A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 - Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 - Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 - Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively. Items Measured at Fair Value on a Recurring Basis The following tables present the Company’s assets and liabilities, by financial instrument type and balance sheet line item that are measured at fair value on a recurring basis, excluding accrued interest components, as of: June 28, 2024 June 30, 2023 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (Dollars in millions) Balance Sheet Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Assets: Money market funds Cash and cash equivalents $ 386 $ — $ — $ 386 $ 72 $ — $ — $ 72 Total cash equivalents 386 — — 386 72 — — 72 Restricted cash and investments: Money market funds Other current assets 1 — — 1 1 — — 1 Time deposits and certificates of deposit Other current assets — 1 — 1 — 1 — 1 Other debt securities Other assets, net — — 15 15 — — 16 16 Derivative assets Other current assets — 1 — 1 — 23 — 23 Total assets $ 387 $ 2 $ 15 $ 404 $ 73 $ 24 $ 16 $ 113 Liabilities: Derivative liabilities Accrued expenses $ — $ (1) $ — $ (1) $ — $ (11) $ — $ (11) Total liabilities $ — $ (1) $ — $ (1) $ — $ (11) $ — $ (11) As of June 28, 2024 and June 30, 2023, the Company’s Other current assets included $2 million in restricted cash equivalents held as collateral at banks for various performance obligations. As of June 28, 2024 and June 30, 2023, the Company had no material available-for-sale investments that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined no impairment related to credit losses for available-for-sale investments as of June 28, 2024 and June 30, 2023. The fair value and amortized cost of the Company’s available-for-sale investments as of June 28, 2024 , was $15 million due in 2 years. The fair value and amortized cost of the Company’s available-for-sale investments as of June 30, 2023 was $16 million with the majority due in 3 years. Items Measured at Fair Value on a Non-Recurring Basis From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under the equity method or the measurement alternative. Investments under the measurement alternative are recorded at cost, less impairment and adjusted for qualifying observable price changes on a prospective basis. If measured at fair value in the Consolidated Balance Sheets, these investments would generally be classified in Level 3 of the fair value hierarchy. For the investments that are accounted for under the equity method, the Company sold certain investments for $14 million and recorded an immaterial gain for fiscal year 2024. The Company recorded a net loss of $29 million for fiscal year 2024, which included $25 million related to downward adjustments to write down the carrying amount of certain investments to their fair value. The Company recorded a net loss of $4 million in fiscal year 2023, and a net gain of $8 million in fiscal year 2022. The adjusted carrying value of the investments accounted under the equity method amounted to $12 million and $55 million as of June 28, 2024 and June 30, 2023 respectively. For the investments that are accounted under the measurement alternative, the Company recorded a net loss of $24 million in fiscal year 2024, related to downward adjustments to write down the carrying amount of certain investments to their fair value. For fiscal years 2023 and 2022, the Company recorded a net loss of $5 million and a net gain of $4 million, respectively. As of June 28, 2024 and June 30, 2023, the carrying value of the Company’s strategic investments under the measurement alternative was $65 million an d $88 million, respectively. Other Fair Value Disclosures The Company’s debt is carried at amortized cost. The estimated fair value of the Company’s debt is derived using the closing price of the same debt instruments as of the date of valuation, which takes into account the yield curve, interest rates and other observable inputs. Accordingly, these fair value measurements are categorized as Level 2. The following table presents the fair value and amortized cost of the Company’s debt in order of maturity: June 28, 2024 June 30, 2023 (Dollars in millions) Carrying Estimated Carrying Estimated 4.75% Senior Notes due January 2025 479 476 479 472 4.875% Senior Notes due June 2027 505 493 504 484 3.50% Exchangeable Senior Notes due June 2028 1,500 2,070 — — 4.091% Senior Notes due June 2029 471 459 465 436 3.125% Senior Notes due July 2029 163 139 163 126 8.25% Senior Notes due December 2029 500 537 500 522 4.125% Senior Notes due January 2031 275 245 275 227 3.375% Senior Notes due July 2031 72 58 72 53 8.50% Senior Notes due July 2031 500 538 500 524 9.625% Senior Notes due December 2032 750 855 750 830 5.75% Senior Notes due December 2034 489 472 489 438 SOFR Based Term Loan A1 due September 2025 — — 430 426 SOFR Based Term Loan A2 due July 2027 — — 430 420 SOFR Based Term Loan A3 due July 2027 — — 430 413 $ 5,704 $ 6,342 $ 5,487 $ 5,371 Less: unamortized debt issuance costs (30) — (36) — Debt, net of debt issuance costs $ 5,674 $ 6,342 $ 5,451 $ 5,371 Less: current portion of debt, net of debt issuance costs (479) (476) (63) (62) Long-term debt, less current portion, net of debt issuance costs $ 5,195 $ 5,866 $ 5,388 $ 5,309

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Jun. 28, 2024
Equity [Abstract]
Shareholders' Equity	Shareholders’ Deficit Share Capital The Company’s authorized share capital is $13,500 and consists of 1,250,000,000 ordinary shares, par value $0.00001, of which 210,182,269 shares were outstanding as of June 28, 2024, and 100,000,000 preferred shares, par value $0.00001, of which none were issued or outstanding as of June 28, 2024. Repurchases of Equity Securities All repurchases are effected as redemptions in accordance with the Company’s Constitution. As of June 28, 2024, $1.9 billion remained available for repurchase under the existing repurchase authorization limit approved by the Board of Directors. The following table sets forth information with respect to repurchases of the Company’s ordinary shares during fiscal years 2024, 2023 and 2022: (In millions) Number of Shares Repurchased Dollar Value of Shares Repurchased Cumulative repurchased through July 2, 2021 426 $ 14,467 Repurchased in fiscal year 2022 (1) 21 1,857 Cumulative repurchased through July 1, 2022 447 16,324 Repurchased in fiscal year 2023 (1) 6 444 Cumulative repurchased through June 30, 2023 453 16,768 Repurchased in fiscal year 2024 (1) 1 38 Cumulative repurchased through June 28, 2024 454 $ 16,806 ___________________________________________________ (1) For fiscal years 2024, 2023 and 2022, includes net share settle ments of $38 million, $44 million and $51 million for 1 million, 1 million a nd 1 million shares, respectively, in connection with tax withholding related to vesting of restricted share units.

Share-based Compensation

Share-based Compensation	12 Months Ended
	Jun. 28, 2024
Share-Based Payment Arrangement [Abstract]
Share-based Compensation	Share-Based Compensation Share-Based Compensation Plans Seagate Technology Holdings plc 2022 Equity Incentive Plan (the “2022 EIP”) : On October 20, 2021, (the “Approval Date”), shareholders of the Company approved the 2022 EIP that replaced Seagate Technology Holdings plc 2012 Equity Inventive Plan (the “2012 EIP”). The 2022 EIP provides for the grant of various types of awards including RSUs, options, PSUs and share appreciation rights. The maximum number of shares that may be delivered to the participants under the 2022 EIP shall not exceed (i) 14.1 million ordinary shares, plus (ii) any shares subject to any outstanding share awards granted under the 2012 EIP that, on or after the Approval Date expire, are cancelled or otherwise terminate, in whole or in part, without having been exercised or redeemed in full, or are settled in cash ((i) and (ii) together being the “Share Reserve”). The maximum aggregate number of shares that may be issued pursuant to RSUs or PSUs (collectively, “Full-Value Share Awards”) shall not exceed 12.3 million ordinary shares. Any shares that are subject to the 2022 EIP will be counted against the Share Reserve as one share for every one share granted. As of June 28, 2024, there were 9.6 million ordinary shares available for issuance of Full-Value Share Awards under the 2022 EIP. Seagate Technology Holdings plc Employee Stock Purchase Plan (the “ESPP”). There are 60 million ordinary shares authorized to be issued under the ESPP. The ESPP consists of a series of six-month offering period with a maximum issuance of 1.5 million ordinary shares per offering period. The ESPP allows eligible employees to contribute up to 10% of their eligible compensation to purchase the Company’s common stock. The price of common stock purchased equals to 85% of the lesser of the fair market value on the first day or the last day of each offering period. During fiscal years 2024, 2023 and 2022, employees purchased approximately 1 million shares each year under this plan at weighted average prices of $54.71, $62.36 and $64.85 per share, respectively. As of June 28, 2024, approximately 5.8 million ordinary shares were available for future issuance. Share-Based Compensation Expense The Company recorded $127 million , $115 million and $145 million of share-based compensation with a resulting tax benefit o f $5 million, $5 million and $15 million, respectiv ely, during fiscal years 2024, 2023 and 2022. Management made an estimate of expected forfeitures and recognized compensation costs only for those equity awards expected to vest. Restricted Stock Units RSUs generally vest over a period of four years, with 25% vesting on the first anniversary of the vesting commencement date and the remaining 75% vesting ratably each quarter over the next 36 months, subject to continuous employment with the Company through the vesting date. The following is a summary of unvested restricted stock activities: Unvested Restricted Stocks Number of Shares (In millions) Weighted-Average Grant-Date Fair Value Unvested at June 30, 2023 3.7 $ 62.07 Granted 2.0 $ 59.96 Forfeited (0.5) $ 62.80 Vested (1.8) $ 59.25 Unvested at June 28, 2024 3.4 $ 62.20 At June 28, 2024, the total unrecognized share-based compensation cost related to unvested restricted stocks was appr oximately $152 million. This cost is being amortized on a straight-line basis over a weighted-average remaining term of 2.3 years and will be adjusted for subsequent changes in estimated forfeitures. The aggregate fair value of restricted stocks vested during fiscal years 2024, 2023 and 2022 were approximately $105 million, $105 million a nd $96 million, respectively. The fair value related to RSUs for fiscal years 2024, 2023 and 2022 were estimated using the following assumptions: Fiscal Years 2024 2023 2022 RSUs Expected term (in years) 1 - 2.2 1 - 2.2 1 - 2.5 Expected dividend rate 2.4 - 4.4% 3.2 - 5.5% 2.4 - 3.4% Weighted-average expected dividend rate 4.0 % 3.8 % 2.8 % Weighted-average fair value $ 59.96 $ 62.82 $ 82.4 The expected term represents the period that the Company’s share-based awards are expected to be outstanding and was determined based on historical experience of similar awards and the expected Dividend yield is determined by dividing the expected per share dividend during the coming year by the grant date share price. Performance-based Share Units The Company granted PSUs that vest on the satisfaction of continuous employment and achievement of certain financial and operational performance goals established by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee ”). These awards vest after the end of the performance period of three year s from the grant date. During fiscal years 2024, 2023 and 2022, the PSUs granted and outstanding were not material. Compensation expense related to these units is only recorded in a period if it is probable that the performance goals will be met, and it is to be recorded at the expected level of achievement. The expenses associated with these PSUs were not material for any of the periods presented. Share Options Options generally vest over a period of four years, with 25% vesting on the first anniversary of the vesting commencement date and the remaining 75% vesting ratably each quarter over the next 36 months, subject to continuous employment with the Company through the vesting date. The exercise price of a share option is equal to the closing price of the Company’s ordinary shares on NASDAQ on the grant date. The expenses associated with share options were not material for any of the periods presented. Employee Savings Plan The Company offers various defined contribution plans for U.S. and non-U.S. employees. In the U.S., qualified employees under the Seagate 401(k) Plan (the "401(k) plan") may elect to make contributions up to 50% of their eligible earned compensation, but not more than statutory limits. Pursuant to the 401(k) plan, the Company matches 50% of employee contributions, up to 6% of compensation, subject to a maximum annual employer contribution of $6,000 per participating employee. During fiscal years 2024, 2023 and 2022, the Company made matching contributions of $65 million, $79 million and $85 million, res

Guarantees

Guarantees	12 Months Ended
	Jun. 28, 2024
Guarantees [Abstract]
Guarantees	Guarantees Indemnifications of Officers and Directors The Company has entered into indemnification agreements with its directors and certain of its officers that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and officers in certain circumstances. The nature of these indemnification obligations prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay on behalf of its officers and directors. Historically, the Company has not made any significant indemnification payments under such indemnification agreements and no amount has been accrued in the Company’s Consolidated Financial Statements with respect to these indemnification obligations. Indemnification Obligations The Company from time to time enters into agreements with customers, suppliers, partners and others in the ordinary course of business that provide indemnification for certain matters including, but not limited to, intellectual property infringement claims, environmental claims and breach of agreement claims. The nature of the Company’s indemnification obligations prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay. Historically, the Compan y has not made any significant indemnification payments under such agreements and no amount has been accrued in the Company’s Consolidated Financial Statements with respect to these indemnification obligations. Product Warranty As of June 28, 2024, the Company’s reserve for product warranty was $149 million compared to $168 million as of June 30, 2023. Changes in the Company’s product warranty liability during the fiscal years ended June 28, 2024, June 30, 2023 and July 1, 2022 were as follows: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Balance, beginning of period $ 168 $ 148 $ 136 Warranties issued 53 55 79 Repairs and replacements (81) (92) (88) Changes in liability for pre-existing warranties, including expirations 9 57 21 Balance, end of period $ 149 $ 168 $ 148

Earnings Per Share

Earnings Per Share	12 Months Ended
	Jun. 28, 2024
Earnings Per Share [Abstract]
Earnings Per Share	(Loss) Per Share Basic earnings per share is computed by dividing income available to shareholders by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed by dividing income available to shareholders by the weighted-average number of shares outstanding during the period and the number of additional shares that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, unvested restricted share units and performance-based share units and shares to be purchased under the Employee Stock Purchase Plan using the treasury stock method, as well as shares issuable in connection with the Company’s exchangeable senior notes using the “if-converted” method. Under the treasury stock method, the dilutive effect of potentially dilutive securities is reflected in diluted net earnings per share and an increase in fair market value of the Company’s share price can result in a greater dilutive effect from potentially dilutive securities. Under the “if-converted” method, diluted earnings per share is calculated assuming that the excess value above the principal of the exchangeable notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be anti-dilutive, which could adversely affect our diluted earnings per share. The following table sets forth the computation of basic and diluted net (loss) income per share attributable to the shareholders of the Company: Fiscal Years Ended (In millions, except per share data) June 28, June 30, July 1, Numerator: Net income (loss) $ 335 $ (529) $ 1,649 Number of shares used in per share calculations: Total shares for purposes of calculating basic net income (loss) per share 209 207 220 Weighted-average effect of dilutive securities: Employee equity award plans 2 — 4 2028 Notes if-converted shares 1 — — Total shares for purposes of calculating diluted net income (loss) per share 212 207 224 Net income (loss) per share Basic $ 1.60 $ (2.56) $ 7.50 Diluted 1.58 (2.56) 7.36 All potentially dilutive securities that could have an anti-dilutive effect on the calculation of the earnings per share have been excluded for the periods presented. The weighted average anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share were not material for the fiscal year ended June 28, 2024, 7 million for the fiscal year ended June 30, 2023 , and not material for the fiscal year ended July 1, 2022.

Commitments

Commitments	12 Months Ended
	Jun. 28, 2024
Commitments Disclosure [Abstract]
Commitments	Commitments Unconditional Long-Term Purchase Obligations. As of June 28, 2024, the Company had unconditional long-term purchase obligations of approx imately $56 million, primarily related to purchases of inventory components. The Company expects the commitment to total $31 million, $15 million, $7 million and $3 million for fiscal years 2026, 2027, 2028 and 2029 respectively . In addition, the Company also had certain long-term market share based inventory purchase commitments as of June 28, 2024. During fiscal year 2024, the Company recorded order cancellatio n fees of $87 million to terminate certain purchase commitments related to the purchase of inventory components and equipment, which was reflected under Cost of revenue in its Consolidated Statements of Operations. As of June 28, 2024, cumulative unpaid order cancellation fees on the Consolidated Balance Sheets were $93 million, with $39 million in Accrued expenses and $54 million in Accounts payable, all of which is expected to be paid within one year. Unconditional Long-Term Capital Expenditures . As of June 28, 2024, the Company had unconditional long-term commitments of approximately $62 million, primarily related to purchases of equipment. The Company expects capital expenditures of $35 million and $27 million for fiscal years 2026 and 2027, respectively.

Business Segment and Geographic

Business Segment and Geographic Information	12 Months Ended
	Jun. 28, 2024
Segment Reporting [Abstract]
Business Segment and Geographic Information	Business Segment and Geographic Information The Company’s manufacturing operations are based on technology platforms that are used to produce various data storage and systems solutions that serve multiple applications and markets. The Company has determined that its Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding investments in the Company’s technology platforms and manufacturing infrastructure based on the Company’s consolidated results. As a result, the Company has concluded that its manufacture and distribution of storage solutions constitutes one operating segment. The following table summarizes the Company’s long-lived assets by country: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Long-lived assets: United States $ 658 $ 667 $ 670 Thailand 574 606 679 Singapore 447 460 557 Other 338 369 426 Consolidated $ 2,017 $ 2,102 $ 2,332

Revenue

Revenue	12 Months Ended
	Jun. 28, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The following table provides information about disaggregated revenue by sales channel and country for the Company’s single reportable segment: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Revenues by Channel OEMs $ 4,896 $ 5,448 $ 8,742 Distributors 972 1,119 1,676 Retailers 683 817 1,243 Total $ 6,551 $ 7,384 $ 11,661 Revenue from external customers (1) : Singapore $ 3,429 $ 3,271 $ 5,322 United States 2,308 3,053 4,694 The Netherlands 802 1,046 1,627 Other 12 14 18 Total $ 6,551 $ 7,384 $ 11,661

Divesture

Divesture	12 Months Ended
	Jun. 28, 2024
Discontinued Operations and Disposal Groups [Abstract]
Divesture	Divestiture Sale of System-on-Chip (“SoC”) Operations On April 23, 2024, the Company entered into an Asset Purchase Agreement with Avago Technologies International Sales Pte. Limited (“Purchaser”), a subsidiary of Broadcom Inc., and sold certain intellectual property, equipment and other assets related to the design, development and manufacture of its SoC products to Purchaser. Purchaser and its affiliates also offered employment to certain of the Company’s employees engaged in the SoC operations. In connection with this transaction, t he Company and Purchaser have also restructured certain pre-existing purchasing agreements (collectively, the “Transaction”). Total consideration for this Transaction was $600 million, including cash proceeds of $560 million at close. The remaining $40 million relates to standard indemnification clauses and is expected to be received before the end of fiscal year 2026 upon fulfillment of certain post-close conditions. Of the held back amount, $25 million was recorded in Other current assets and $15 million in Other assets, net on the Consolidated Balance Sheets as of June 28, 2024. The agreement also contains regulatory review indemnification clauses agreed to by both parties in conjunction with the transaction closing. Based on the valuation performed by the Company, $234 million of the consideration was attributable to the restructuring of pre-existing purchase agreements and recorded as a deferred liability within Other non-current liabilities on the Consolidated Balance Sheets as of June 28, 2024. The deferred liability is expected to be recognized ratably over the terms of the restructured purchase agreements. Estimating the fair value of the restructuring of pre-existing purchase agreements is judgmental in nature and involves the use of estimates and assumptions. The Company estimated the fair value of its restructuring of pre-existing purchase agreements using the market approach based on discounted cash flow analysis of management’s short-term and long-term forecast of purchase volume and average market price. The discount rate used is based on the weighted-average cost of capital of comparable public companies adjusted for the relevant risk associated with business specific characteristics. This deferred liability is classified in Level 3 of the fair value hierarchy. As a result of the Transaction, the Company recorded a pre-tax net gain of $313 million from the sale of assets and transfer of liabilities, which included $18 million of goodwill allocated to SoC operations based on its relative fair value of the Company because the disposal group constituted a business for accounting purposes. This was recorded in the Net gain from business divestiture in the Consolidated Statements of Operations during fiscal year 2024. For the fiscal year 2024, the net proceeds of $226 million, net of transaction costs paid, from this Transaction was recorded as an operating inflow and $326 million was recorded as an investing inflow on the Company’s Consolidated Statements of Cash Flows. The Transaction did not meet the criteria of discontinued operation because the disposal did not represent a strategic shift that had a major effect on the Company’s operations and financial results.

Subsequent Events

Subsequent Events	12 Months Ended
	Jun. 28, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Event Dividend Declared On July 23, 2024, the Board of Directors of the Company declared a quarterly cash dividend of $0.70 per share, which will be payable on October 7, 2024 to shareholders of record as of the close of business on September 23, 2024 .

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Pay vs Performance Disclosure
Net income (loss)	$ 335	$ (529)	$ 1,649

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Jun. 28, 2024 shares	Jun. 28, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		The table below summarizes the material terms of trading arrangements adopted by any of our executive officers or directors during the fiscal quarter ended June 28, 2024. All of the trading arrangements listed below are intended to satisfy the affirmative defense of Rule 10b5-1(c). Name Title Date of Adoption End Date¹ Aggregate number of ordinary shares to be sold pursuant to the trading agreement Dr. William D. Mosley Chief Executive Officer and Director May 6, 2024 April 30, 2025 476,132 Gianluca Romano Executive Vice President and Chief Financial Officer May 1, 2024 December 31, 2024 25,760 Yolanda Conyers Director June 5, 2024 September 30, 2025 3,750 ___________________________________ ¹ The plan will expire on the earlier of the end date or the completion of all transactions under the trading arrangement.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Dr. William D. Mosley [Member]
Trading Arrangements, by Individual
Name	Dr. William D. Mosley
Title	Chief Executive Officer and Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 6, 2024
Arrangement Duration	359 days
Aggregate Available	476,132	476,132
Gianluca Romano [Member]
Trading Arrangements, by Individual
Name	Gianluca Romano
Title	Executive Vice President and Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 1, 2024
Arrangement Duration	244 days
Aggregate Available	25,760	25,760
Yolanda Conyers [Member]
Trading Arrangements, by Individual
Name	Yolanda Conyers
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 5, 2024
Aggregate Available	3,750	3,750
Ban Seng Teh [Member]
Trading Arrangements, by Individual
Arrangement Duration	482 days

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Jun. 28, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 28, 2024
Significant Accounting Policies
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation
Fiscal Period	The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. Fiscal years 2024, 2023 and 2022 are comprised of 52 weeks and ended on June 28, 2024, June 30, 2023 and July 1, 2022, respectively. All references to years in these Notes to Consolidated Financial Statements represent fiscal years unless otherwise noted. Fiscal year 2026 will be comprised of 53 weeks and will end on July 3, 2026.
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Cash and Cash Equivalents. The Company considers all highly liquid investments with a remaining maturity of 90 days or less at the time of purchase to be cash equivalents. The Company’s highly liquid investments are primarily comprised of money market funds, time deposits and certificates of deposits. Restricted Cash and Cash Equivalents. Restricted cash and cash equivalents represent cash and cash equivalents held as collateral at banks for various performance obligations.
Allowance for Expected Credit Loss	Allowance for expected credit loss. The Company maintains an allowance for expected credit loss relating to its accounts receivable based upon expected collectability. This reserve is established based upon historical trends, global macroeconomic conditions, reasonable and supportable forecasts of future conditions and an analysis of specific exposures. The provision for expected credit loss is recorded as a charge to Marketing and administrative expense in the Company’s Consolidated Statements of Operations.
Inventory	Inventories. Inventories are valued at the lower of cost (using the first-in, first-out method) and net realizable value. Net realizable value is based upon the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Adjustments to reduce cost of inventories to its net realizable value are made, if required, for estimated excess or obsolescence determined primarily by future demand forecasts.
Property, Equipment and Leasehold Improvements	Property, Equipment and Leasehold Improvements. Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Equipment and buildings are depreciated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated life of the asset or the remaining term of the lease. The costs of additions and substantial improvements to property, equipment and leasehold improvements, which extend the economic life of the underlying assets, are capitalized. The cost of maintenance and repairs to property, equipment and leasehold improvements is expensed as incurred. In accordance with its policy, the Company reviews the estimated useful lives of its fixed assets on an ongoing basis. Effective from the first quarter of fiscal year 2024, the Company changed the useful lives of certain manufacturing equipment from a range of three three effect of this change in estimate increased the net incom e by $99 million and increased the diluted earnings per share by $0.47 for th e fiscal year ended June 28, 2024 .
Assessment of Goodwill and Other Long-Lived Assets for Impairment	Goodwill. The Company performs a qualitative assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in the overall industry that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill. If it is determined in the qualitative assessment that the fair value of a reporting unit is more likely than not below its carrying amount, including goodwill, then the Company will perform a quantitative impairment test. The quantitative goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Any excess in the carrying value of a reporting unit over its fair value is recognized as an impairment loss, limited to the total amount of goodwill allocated to that reporting unit. Other Long-lived Assets.
Assets Held For Sale	Assets Held for Sale. The Company classifies its long-lived assets to be sold as held for sale in the period (i) it has approved and committed to a plan to sell the asset, (ii) the asset is available for immediate sale in its present condition, (iii) an active program to locate a buyer and other actions required to sell the asset have been initiated, (iv) the sale of the asset is probable, (v) the asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. The Company initially measures a long-lived asset that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset until the date of sale. Upon designation as an asset held for sale, the Company stops recording depreciation expense on the asset. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.
Leases	Leases. The Company determines if an arrangement is a lease or contains a lease at inception. Right-of-use (“ROU”) assets are included in Other assets, net and lease liabilities are included in Accrued expenses and Other non-current liabilities in the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and the corresponding lease liabilities represent its obligation to make lease payments arising from the lease. The Company combines lease and non-lease components for facility leases and does not recognize ROU assets and lease liabilities for leases with an initial term of 12 months or less on the Consolidated Balance Sheets. Lease liabilities are measured at the present value of the remaining lease payments and ROU assets are based on the lease liability, adjusted for lease prepayments, lease incentives received and the lessee’s initial direct costs. For the Company’s leases that do not provide an implicit rate, the net present value of future minimum lease payments is determined using the Company’s estimated incremental borrowing rate based on the information available at the lease commencement date. Additionally, the Company’s lease term may include options to extend or terminate the lease. These options are reflected in the ROU asset and lease liability when it is reasonably certain that the Company will exercise the option. The Company’s lease agreements do not contain any material residual value guarantees.
Derivative Financial Instruments	Derivative Financial Instruments. The Company records all derivatives on the balance sheet at fair value and establishes criteria for designation and effectiveness of hedging relationships. Foreign currency forward exchange contracts are used to economically hedge the foreign currency exposure on forecasted expenditures in currencies other than U.S. dollar. The Company also enters into foreign currency forward contracts with contractual maturities of less than one month, which are designed to mitigate the effect of changes in foreign exchange rates on monetary assets and liabilities. The Company determines the fair value of these instruments by considering the estimated amount it would pay or receive to terminate these agreements at the reporting date. The changes in the fair value of highly effective designated cash flow hedges are recorded in Accumulated Other Comprehensive Income (“AOCI”) until the hedged item is recognized in earnings. The Company excludes the change in forward points from the assessment of hedge effectiveness and recognizes the excluded component in Other, net in the Consolidated Statements of Operations. The Company de-designates its cash flow hedges when the forecasted hedged transactions affect earnings or it is probable the forecasted hedged transactions will not occur in the initially identified time period. At such time, the associated gains and losses deferred in AOCI on the Company’s Consolidated Balance Sheets are reclassified into earnings and any subsequent changes in the fair value of such derivative instruments are immediately reflected in earnings. The Company recognizes the unrealized gains and losses due to the changes in the fair value of derivatives that are not designated as hedging instruments or are not assessed to be highly effective in Other, net in the Consolidated Statements of Operations. The Company recognizes gains and losses from foreign currency forward exchange contracts within Other non-cash operating activities in the Consolidated Statements of Cash Flows. The Company is exposed to foreign currency exchange rate, interest rate and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements was to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. On September 13, 2023, the Company terminated its then existing interest rate swap agreements as a result of the repayment of Term Loans A1, A2 and A3 and received cash proceeds of $25 million from the counterparty. The cash proceeds are reported within Net cash provided by operating activities in the Company’s Consolidated Statements of Cash Flows during the fiscal year ended 2024. The Company discontinued the related hedge accounting prospectively and realized a net gain of $104 million in Net gain from termination of interest rate swap in the Consolidated Statements of Operations during the fiscal year ended 2024. Additionally, $6 million of the gains were amortized to Interest expense prior to the termination of interest rate swap in the Company’s Consolidated Statements of Operations. Refer to “ Note 4. Debt ” for more details. As of June 28, 2024, the Company does not have any interest rate swap contracts. The net unrealized loss on cash flow hedges was immaterial as of June 28, 2024. The net unrealized gain on cash flow hedges was $12 million as of June 30, 2023.
Establishment of Warranty Accruals	Warranty. The Company estimates probable product warranty costs at the time revenue is recognized. The Company generally provides warranty on its products for a period of 1 to 5 years. The Company's warranty provision considers estimated product failure rates, trends (including the timing of product returns during the warranty periods), and estimated repair or replacement costs related to product quality issues, if any. The Company also exercises judgment in estimating its ability to sell refurbished products. Product Warranty
Revenue Recognition, Sales Returns and Allowances, and Sales Incentive Programs	Revenue Recognition and Sales Incentive Programs. The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue from sales of products is generally recognized upon transfer of control to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products, net of sales taxes. This typically occurs upon shipment from the Company. When applicable, the Company includes shipping charges billed to customers in Revenue and includes the related shipping costs in Cost of revenue on the Company's Consolidated Statements of Operations. The Company records estimated variable consideration at the time of revenue recognition as a reduction to revenue. Variable consideration generally consists of sales incentive programs, such as price protection and volume incentives aimed at increasing customer demand. For original equipment manufacturers (“OEMs”) sales, rebates are typically established by estimating the most likely amount of consideration expected to be received based on an OEM customer’s volume of purchases from the Company or other agreed upon rebate programs. For the distribution and retail channel, these programs typically involve estimating the most likely amount of rebates related to a customer’s level of sales, order size, advertising or point of sale activity as well as the expected value of price protection adjustments based on historical analysis and forecasted pricing environment. Marketing development program costs are accrued and recorded as a reduction to revenue at the same time that the related revenue is recognized. At the end of the reporting period, the Company has unfulfilled product purchase orders which represent performance obligations not delivered, or partially undelivered under existing customer contracts. Some of these purchase orders are non-cancellable in nature. As of June 28, 2024, all non-cancellable purchase orders are less than one year in duration and are expected to be fulfilled in the next twelve months. The Company applied optional exemption to not disclose the value of these remaining performance obligations as they are part of a contract that has an original expected duration of one year or less.
Restructuring Costs	Restructuring Costs.
Advertising Expense	Advertising Expense. The cost of advertising is expensed as incurred. Advertising costs were approximately $18 million
Stock-Based Compensation	Share-Based Compensation.
Accounting for Income Taxes	Accounting for Income Taxes . The Company records a provision or benefit for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred income tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, as well as for loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company recognizes the deferred income tax effects of a change in tax rates in the period of the enactment. The Company periodically reassesses the need for valuation allowances on the deferred tax assets, considering both positive and negative evidence to evaluate whether it is more likely than not that all or a portion of such assets will not be realized. The Company recognizes a tax benefit only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement.
Financial Instruments Remeasurement	Equity Investments. From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under equity method or the measurement alternative. These investments are included in Other assets, net in the Company's Consolidated Balance Sheets and are subsequently adjusted through Other, net in the Consolidated Statements of Operations. Investments are accounted for under the equity method if the Company has the ability to exercise significant influence, but does not have a controlling financial interest. These investments are measured at cost, less any impairment plus the Company's portion of investee’s income or loss. The Company uses the financial statements of investees to determine any adjustments, which are received on a one-quarter lag. For equity investments where the Company does not have the ability to exercise significant influence and there are no readily determinable fair values, the Company has elected to apply the measurement alternative, under which investments are measured at cost, less impairment, and adjusted for qualifying observable price changes on a prospective basis. The Company’s strategic investments are periodically analyzed to determine whether or not there are indicators of impairment by assessing factors such as deterioration of earnings, adverse change in market/industry conditions, the ability to operate as a going concern, and other factors which indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Consolidated Statements of Operations.
Foreign Currency Remeasurement and Translation	Foreign Currency Remeasurement and Translation. The U.S. dollar is the functional currency for the majority of the Company's foreign operations. Monetary assets and liabilities denominated in foreign currencies are remeasured into the functional currency at the balance sheet date at exchange rates in effect at the end of each period. The gains and losses from the remeasurement are included in Other, net in the Company's Consolidated Statements of Operations. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized in foreign currency translation included in Accumulated other comprehensive income, which is a component of Shareholders’ Deficit. Government Incentives. The Company enters into government incentive arrangements with domestic and foreign, local, regional and national governments, which vary in size, duration and conditions. In fiscal year 2024, approximately $3 million of operating grants were recognized as reductions to Cost of revenue $17 million , which were reflected within Accrued expenses in the Company's Consolidated Balance Sheets. In fiscal year 2023, approximately $13 million of operating grants were recognized as reductions to Cost of revenue Use of Estimates The preparation of financial statements requires management to make estimates, judgments and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Estimates are assessed each period and updated to reflect current information, including those related to revenue recognition, share-based compensation, restructuring accruals, provision for taxes, valuation allowance for deferred taxes, provision for expected credit losses, inventory reserves, warranty accruals, and impairment assessments of goodwill, intangible assets and other long-lived assets. The Company believes that these estimates, judgments and assumptions are reasonable under the circumstances, and are subject to significant uncertainties, some of which are beyond the Company's control. Should any of these estimates change, it could adversely affect
Concentration of Credit Risk	Concentration of Credit Risk. The Company’s customer base is concentrated with a small number of customers. The Company does not generally require collateral or other security to support accounts receivable. To reduce credit risk, the Company performs ongoing credit evaluations on its customers’ financial condition. The Company establishes allowances for expected credit losses based upon factors surrounding the credit risk of customers, global macroeconomic conditions and an analysis of specific exposures. One customer and two customers accounted for more than 10% of the Company’s accounts receivable as of June 28, 2024 and June 30, 2023, respectively . Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and foreign currency forward exchange contracts. The Company maintains the cash and cash equivalents with four major financial institutions and a portion of such balances exceed or are not subject to Federal Deposit Insurance Corporation, or FDIC, insurance limits. The Company mitigates concentrations of credit risk in its financial instruments through diversification, by investing in highly-rated securities and/or major multinational companies. In entering into foreign currency forward exchange contracts, the Company assumes the risk that might arise from the possible inability of counterparties to meet the terms of their contracts. The counterparties to these contracts are major multinational commercial and investment banks, and the Company has not incurred and does not expect any losses as a result of counterparty defaults.
Concentration Risk, Supplier	Supplier Concentration. Certain of the raw materials, components and equipment used by the Company in the manufacture of its products are available from single-sourced direct and indirect vendors. Shortages could occur in these essential materials and components due to an interruption of supply or increased demand in the industry. If the Company were unable to procure certain materials, components or equipment at all or acceptable prices, it would be required to reduce its manufacturing operations, which could have a material adverse effect on its results of operations.
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements In September 2022, the Financial Accounting Standards Board (FASB) issued ASU 2022-04 (ASC Subtopic 405-50), Disclosure of Supplier Finance Program Obligations. This ASU requires disclosure of key terms of the outstanding supplier finance programs and a roll forward of the related obligations. The Company adopted this guidance during the first quarter of fiscal year 2024, except for the disclosure on rollforward information which will be adopted in fiscal year 2025, in line with the effective adoption date prescribed by the FASB. The adoption of this ASU did not have a material impact on the Company’s Consolidated Financial Statements. Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07 (ASC Topic 280), Improvements to Reportable Segment Disclosures . This ASU improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. This standard is expected to impact the Company’s disclosures and will not have impact on its Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09 (ASC Topic 740), Improvements to Income Tax Disclosures
Fair Value, Policy	Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company's own assumptions of market participant valuation (unobservable inputs). A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 - Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 - Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 - Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Policies)	12 Months Ended
	Jun. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments. The Company records all derivatives on the balance sheet at fair value and establishes criteria for designation and effectiveness of hedging relationships. Foreign currency forward exchange contracts are used to economically hedge the foreign currency exposure on forecasted expenditures in currencies other than U.S. dollar. The Company also enters into foreign currency forward contracts with contractual maturities of less than one month, which are designed to mitigate the effect of changes in foreign exchange rates on monetary assets and liabilities. The Company determines the fair value of these instruments by considering the estimated amount it would pay or receive to terminate these agreements at the reporting date. The changes in the fair value of highly effective designated cash flow hedges are recorded in Accumulated Other Comprehensive Income (“AOCI”) until the hedged item is recognized in earnings. The Company excludes the change in forward points from the assessment of hedge effectiveness and recognizes the excluded component in Other, net in the Consolidated Statements of Operations. The Company de-designates its cash flow hedges when the forecasted hedged transactions affect earnings or it is probable the forecasted hedged transactions will not occur in the initially identified time period. At such time, the associated gains and losses deferred in AOCI on the Company’s Consolidated Balance Sheets are reclassified into earnings and any subsequent changes in the fair value of such derivative instruments are immediately reflected in earnings. The Company recognizes the unrealized gains and losses due to the changes in the fair value of derivatives that are not designated as hedging instruments or are not assessed to be highly effective in Other, net in the Consolidated Statements of Operations. The Company recognizes gains and losses from foreign currency forward exchange contracts within Other non-cash operating activities in the Consolidated Statements of Cash Flows. The Company is exposed to foreign currency exchange rate, interest rate and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements was to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. On September 13, 2023, the Company terminated its then existing interest rate swap agreements as a result of the repayment of Term Loans A1, A2 and A3 and received cash proceeds of $25 million from the counterparty. The cash proceeds are reported within Net cash provided by operating activities in the Company’s Consolidated Statements of Cash Flows during the fiscal year ended 2024. The Company discontinued the related hedge accounting prospectively and realized a net gain of $104 million in Net gain from termination of interest rate swap in the Consolidated Statements of Operations during the fiscal year ended 2024. Additionally, $6 million of the gains were amortized to Interest expense prior to the termination of interest rate swap in the Company’s Consolidated Statements of Operations. Refer to “ Note 4. Debt ” for more details. As of June 28, 2024, the Company does not have any interest rate swap contracts. The net unrealized loss on cash flow hedges was immaterial as of June 28, 2024. The net unrealized gain on cash flow hedges was $12 million as of June 30, 2023.

Balance Sheet Information (Tabl

Balance Sheet Information (Tables)	12 Months Ended
	Jun. 28, 2024
Disclosure Text Block Supplement [Abstract]
Cash, Cash Equivalent, and Restricted Cash	The following table provides a summary of cash, cash equivalents and restricted cash reported within the Company’s Consolidated Balance Sheets that reconciles to the corresponding amount in the Company’s Consolidated Statements of Cash Flows: (Dollars in millions) June 28, June 30, July 1, Cash and cash equivalents $ 1,358 $ 786 $ 615 Restricted cash included in Other current assets 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 1,360 $ 788 $ 617
Schedule of Cash and Cash Equivalents	The following table provides a summary of cash, cash equivalents and restricted cash reported within the Company’s Consolidated Balance Sheets that reconciles to the corresponding amount in the Company’s Consolidated Statements of Cash Flows: (Dollars in millions) June 28, June 30, July 1, Cash and cash equivalents $ 1,358 $ 786 $ 615 Restricted cash included in Other current assets 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 1,360 $ 788 $ 617
Accounts Receivable, net	The details of the accounts receivable, net were as follows: (Dollars in millions) June 28, June 30, Accounts receivable $ 433 $ 625 Allowances for expected credit losses (4) (4) Account receivable, net $ 429 $ 621
Accounts Receivable, Allowance for Credit Loss	Activity in the expected credit losses accounts was as follows: (Dollars in millions) Balance at Beginning of Period Charges (Credit) to Operations Balance at End of Period Fiscal year ended July 1, 2022 $ 4 — $ 4 Fiscal year ended June 30, 2023 $ 4 — $ 4 Fiscal year ended June 28, 2024 $ 4 — $ 4
Inventories	The details of the inventory, net were as follows: (Dollars in millions) June 28, June 30, Raw materials and components $ 270 $ 241 Work-in-process 831 682 Finished goods 138 217 Total inventories, net $ 1,239 $ 1,140
Schedule of Other Current Assets	The details of the other current assets were as follows: (Dollars in millions) June 28, June 30, Vendor receivables $ 110 $ 167 Other current assets 196 191 Total $ 306 $ 358
Property, Equipment and Leasehold Improvements, net	The components of property, equipment and leasehold improvements, net were as follows: (Dollars in millions) Useful Life in Years June 28, June 30, Land and land improvements $ 18 $ 21 Equipment 3 – 10 8,632 8,504 Buildings and leasehold improvements Up to 30 1,412 1,435 Construction in progress 198 307 Gross property, equipment and leasehold improvements 10,260 10,267 Less: accumulated depreciation and amortization (8,646) (8,561) Property, equipment and leasehold improvements, net $ 1,614 $ 1,706
Accrued Expenses	The details of the accrued expenses were as follows: (Dollars in millions) June 28, June 30, Dividends payable $ 147 $ 145 Other accrued expenses 507 603 Total $ 654 $ 748
Accumulated Other Comprehensive Income (Loss)	The components of AOCI, net of tax, were as follows: (Dollars in millions) Unrealized Gains/(Losses) on Cash Flow Hedges Unrealized Gains/(Losses) on Post-Retirement Plans Foreign Currency Translation Adjustments Total Balance at July 1, 2022 $ 51 $ (14) $ (1) $ 36 Other comprehensive income before reclassifications 65 11 — 76 Amounts reclassified from AOCI (13) (1) — (14) Other comprehensive income 52 10 — 62 Balance at June 30, 2023 103 (4) (1) 98 Other comprehensive (loss) income before reclassifications (13) 1 1 (11) Amounts reclassified from AOCI (90) 1 — (89) Other comprehensive (loss) income (103) 2 1 (100) Balance at June 28, 2024 $ — $ (2) $ — $ (2)

Debt (Tables)

Debt (Tables)	12 Months Ended
	Jun. 28, 2024
Debt Disclosure [Abstract]
Schedule of Debt	The following table provides details of the Company’s debt as of June 28, 2024 and June 30, 2023: (Dollars in millions) June 28, June 30, Unsecured Senior Notes (1) $1,000 issued on May 28, 2014 at 4.75% due January 1, 2025 (the “2025 Notes”) , interest payable semi-annually on January 1 and July 1 of each year. 479 479 $700 issued on May 14, 2015 at 4.875% due June 1, 2027 (the “2027 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 505 504 $500 issued on June 18, 2020 at 4.091% due June 1, 2029 (the “June 2029 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 471 465 $500 issued on December 8, 2020 at 3.125% due July 15, 2029 (the “July 2029 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 163 163 $500 issued on May 30, 2023 at 8.25% due December 15, 2029 ( the “December 2029 Notes” ), interest payable semi-annually on June 15 and December 15 of each year. 500 500 $500 issued on June 10, 2020 at 4.125% due January 15, 2031 (the “January 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 275 275 $500 issued on December 8, 2020 at 3.375% due July 15, 2031 (the “July 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 72 72 $500 issued on May 30, 2023 at 8.50% due July 15, 2031 ( the “8.50% July 2031 Notes” ), interest payable semi-annually on January 15 and July 15 of each year. 500 500 $750 issued on November 30, 2022 at 9.625% due December 1, 2032 (the “2032 Notes”), interest payable semi-annually on June 1 and December 1 of each year. 750 750 $500 issued on December 2, 2014 at 5.75% due December 1, 2034 (the “2034 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 489 489 Exchangeable Senior Notes (1) $1,500 issued on September 13, 2023 at 3.50% due June 1, 2028 ( the “2028 Notes” ), interest payable semi-annually on March 1 and September 1 of each year. 1,500 — Term Loans $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.125% to 2.375%, ( the “Term Loan A1”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of September 16, 2025. — 430 $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A2”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. — 430 $600 borrowed on August 18, 2022 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A3 ”), repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. — 430 5,704 5,487 Less: unamortized debt issuance costs (30) (36) Debt, net of debt issuance costs 5,674 5,451 Less: current portion of long-term debt (479) (63) Long-term debt, less current portion $ 5,195 $ 5,388 ___________________________________ (1 ) All unsecured senior notes and exchangeable senior notes are issued by Seagate HDD Cayman (“Seagate HDD”), and the obligations under these notes are fully and unconditionally guaranteed, on a senior unsecured basis, by Seagate Technology Unlimited Company (“STUC”) and STX.
Future principal payments on long-term debt	At June 28, 2024, future principal payments on long-term debt were as follows (in millions): Fiscal Year Amount 2025 $ 479 2026 — 2027 505 2028 1,500 2029 495 Thereafter 2,750 Total $ 5,729

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 28, 2024
Income Tax Disclosure [Abstract]
Schedule of Income Before Income Tax Expense (Benefit)	before income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, U.S. $ 249 $ 300 $ 145 Non-U.S. 196 (796) 1,534 $ 445 $ (496) $ 1,679
Schedule of Provision For (Benefits From) Income Taxes	The provision for income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Current income tax expense: U.S. $ 2 $ 6 $ 4 Non-U.S. 30 17 35 Total Current 32 23 39 Deferred income tax expense/(benefit): U.S. 71 9 3 Non-U.S. 7 1 (12) Total Deferred 78 10 (9) Provision for income taxes $ 110 $ 33 $ 30
Schedule of Deferred Tax Assets and Liabilities	The significant components of the Company’s deferred tax assets and liabilities were as follows: Fiscal Years Ended (Dollars in millions) June 28, June 30, Deferred tax assets Accrued warranty $ 37 $ 38 Inventory carrying value adjustments 32 40 Receivable allowances 9 11 Accrued compensation and benefits 36 43 Capitalized research expenses — 119 Depreciation 19 40 Restructuring accruals 2 14 Lease liabilities 64 62 Other accruals and deferred items 11 14 Net operating losses 613 542 Tax credit carryforwards 593 619 Capital loss carryforwards 67 — Other assets 40 1 Gross: Deferred tax assets 1,523 1,543 Less: Valuation allowance (430) (370) Net: Deferred tax assets 1,093 1,173 Deferred tax liabilities Unremitted earnings of certain non-U.S. entities (4) (4) Acquisition-related items (1) (1) Right-of-use assets (63) (62) Other liabilities — (2) Net: Deferred tax liabilities (68) (69) Total net deferred tax assets $ 1,025 $ 1,104
Schedule of Reconciliation Between the Provision for Income Taxes at the Statutory Rate and the Effective Tax Rate	We established Singapore as our principal executive offices in fiscal year 2024. The Singaporean statutory tax rate of 17% is used for purposes of the reconciliation between the provision for income taxes at the statutory rate and our effective tax rate. For fiscal years 2023 and 2022, a notional Irish statutory rate of 25% was used. Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Provision (benefit) at statutory rate $ 76 $ (124) $ 420 Permanent differences 5 8 5 Valuation allowance 47 (18) 7 Effect of rates different than statutory (2) 178 (371) Research credit (9) (18) (26) Capital loss carryforward (11) — — Other individually immaterial items 4 7 (5) Provision for income taxes $ 110 $ 33 $ 30
Schedule of Gross Unrecognized Tax Benefits	The following table summarizes the activities related to the Company’s gross unrecognized tax benefits: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Balance of unrecognized tax benefits at the beginning of the year $ 116 $ 114 $ 108 Gross increase for tax positions of prior years 3 — 1 Gross decrease for tax positions of prior years (12) (4) (1) Gross increase for tax positions of current year 5 7 6 Gross decrease for tax positions of current year — (1) — Balance of unrecognized tax benefits at the end of the year $ 112 $ 116 $ 114

Leases, Codification Topic 842

Leases, Codification Topic 842 (Tables)	12 Months Ended
	Jun. 28, 2024
Leases [Abstract]
Lease, Cost	Operating lease costs include short-term lease costs and are shown net of immaterial sublease income. The components of lease costs and other information related to leases were as follows: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Operating lease cost $ 72 $ 21 $ 16 Variable lease cost 3 3 4 Total lease cost $ 75 $ 24 $ 20 Operating cash outflows from operating leases $ 63 $ 23 $ 20 During fiscal years 2024 and 2023, the Company obtained $47 million and $353 million ROU assets in exchange for new operating lease liabilities, respectively. In fiscal year 2022, the ROU assets obtained in exchange for new operating lease liabilities were immaterial. June 28, June 30, July 1, Weighted-average remaining lease term 8.6 years 9.6 years 9.3 years Weighted-average discount rate 8.45 % 8.49 % 6.40 % ROU assets and lease liabilities included in the Company’s Consolidated Balance Sheets were as follows: (Dollars in millions) Balance Sheet Location June 28, June 30, ROU assets Other assets, net $ 403 $ 396 Current lease liabilities Accrued expenses 61 51 Non-current lease liabilities Other non-current liabilities 338 333
Lessee, Operating Lease, Liability, Maturity	At June 28, 2024, future lease payments included in the measurement of lease liabilities were as follows (in millions): Fiscal Year Amount 2025 $ 63 2026 64 2027 59 2028 60 2029 62 Thereafter 256 Total lease payments 564 Less: imputed interest (165) Present value of lease liabilities $ 399

Restructuring and Exit Costs (T

Restructuring and Exit Costs (Tables)	12 Months Ended
	Jun. 28, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Cost Type	The following table summarizes the Company’s restructuring activities under its active restructuring plans for fiscal years 2024, 2023 and 2022: April 2023 Plan October 2022 Plan Other Plans (Dollars in millions) Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Total Accrual Balance at July 2, 2021 $ — $ — $ — $ — $ 2 $ 6 $ 8 Restructuring charges — — — — 2 1 3 Cash payments — — — — (4) (2) (6) Accrual Balance at July 1, 2022 — — — — — 5 5 Restructuring charges 145 3 104 7 10 — 269 Cash payments (37) (3) (103) (1) (10) (1) (155) Adjustments — — — (1) 1 — — Accrual Balance at June 30, 2023 108 — 1 5 1 4 119 Restructuring charges — — — — 6 1 7 Cash payments (106) — (1) (3) (5) (1) (116) Adjustments (1) — — (1) — (4) (6) Accrual Balance at June 28, 2024 $ 1 $ — $ — $ 1 $ 2 $ — $ 4 Total costs incurred to date as of June 28, 2024 $ 144 $ 3 $ 104 $ 5 $ 70 $ 10 $ 336 Total expected costs to be incurred as of June 28, 2024 $ — $ — $ — $ — $ — $ — $ —

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Jun. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of gross fair value of derivative instruments	The gross notional and fair value of derivative instruments in the Consolidated Balance Sheets as of June 28, 2024 and June 30, 2023 were as follows: As of June 28, 2024 Derivative Assets Derivative Liabilities (Dollars in millions) Outstanding Gross Notional Balance Sheet Fair Value Balance Sheet Fair Value Derivatives designated as hedging instruments: Foreign currency forward exchange contracts $ 35 Other current assets $ — Accrued expenses $ (1) Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts 165 Other current assets 1 Accrued expenses — Total return swap 112 Other current assets — Accrued expenses — Total derivatives $ 312 $ 1 $ (1) As of June 30, 2023 Derivative Assets Derivative Liabilities (Dollars in millions) Outstanding Gross Notional Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedging instruments: Foreign currency forward exchange contracts $ 445 Other current assets $ 2 Accrued expenses $ (10) Interest rate swap 1,288 Other current assets 20 Accrued expenses — Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts 197 Other current assets — Accrued expenses (1) Total return swap 108 Other current assets 1 Accrued expenses — Total derivatives $ 2,038 $ 23 $ (11)

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Jun. 28, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables present the Company’s assets and liabilities, by financial instrument type and balance sheet line item that are measured at fair value on a recurring basis, excluding accrued interest components, as of: June 28, 2024 June 30, 2023 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (Dollars in millions) Balance Sheet Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Assets: Money market funds Cash and cash equivalents $ 386 $ — $ — $ 386 $ 72 $ — $ — $ 72 Total cash equivalents 386 — — 386 72 — — 72 Restricted cash and investments: Money market funds Other current assets 1 — — 1 1 — — 1 Time deposits and certificates of deposit Other current assets — 1 — 1 — 1 — 1 Other debt securities Other assets, net — — 15 15 — — 16 16 Derivative assets Other current assets — 1 — 1 — 23 — 23 Total assets $ 387 $ 2 $ 15 $ 404 $ 73 $ 24 $ 16 $ 113 Liabilities: Derivative liabilities Accrued expenses $ — $ (1) $ — $ (1) $ — $ (11) $ — $ (11) Total liabilities $ — $ (1) $ — $ (1) $ — $ (11) $ — $ (11) As of June 28, 2024 and June 30, 2023, the Company’s Other current assets included $2 million in restricted cash equivalents held as collateral at banks for various performance obligations. As of June 28, 2024 and June 30, 2023, the Company had no material available-for-sale investments that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined no impairment related to credit losses for available-for-sale investments as of June 28, 2024 and June 30, 2023.
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	The Company’s debt is carried at amortized cost. The estimated fair value of the Company’s debt is derived using the closing price of the same debt instruments as of the date of valuation, which takes into account the yield curve, interest rates and other observable inputs. Accordingly, these fair value measurements are categorized as Level 2. The following table presents the fair value and amortized cost of the Company’s debt in order of maturity: June 28, 2024 June 30, 2023 (Dollars in millions) Carrying Estimated Carrying Estimated 4.75% Senior Notes due January 2025 479 476 479 472 4.875% Senior Notes due June 2027 505 493 504 484 3.50% Exchangeable Senior Notes due June 2028 1,500 2,070 — — 4.091% Senior Notes due June 2029 471 459 465 436 3.125% Senior Notes due July 2029 163 139 163 126 8.25% Senior Notes due December 2029 500 537 500 522 4.125% Senior Notes due January 2031 275 245 275 227 3.375% Senior Notes due July 2031 72 58 72 53 8.50% Senior Notes due July 2031 500 538 500 524 9.625% Senior Notes due December 2032 750 855 750 830 5.75% Senior Notes due December 2034 489 472 489 438 SOFR Based Term Loan A1 due September 2025 — — 430 426 SOFR Based Term Loan A2 due July 2027 — — 430 420 SOFR Based Term Loan A3 due July 2027 — — 430 413 $ 5,704 $ 6,342 $ 5,487 $ 5,371 Less: unamortized debt issuance costs (30) — (36) — Debt, net of debt issuance costs $ 5,674 $ 6,342 $ 5,451 $ 5,371 Less: current portion of debt, net of debt issuance costs (479) (476) (63) (62) Long-term debt, less current portion, net of debt issuance costs $ 5,195 $ 5,866 $ 5,388 $ 5,309

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Jun. 28, 2024
Equity [Abstract]
Schedule of Share Repurchases	The following table sets forth information with respect to repurchases of the Company’s ordinary shares during fiscal years 2024, 2023 and 2022: (In millions) Number of Shares Repurchased Dollar Value of Shares Repurchased Cumulative repurchased through July 2, 2021 426 $ 14,467 Repurchased in fiscal year 2022 (1) 21 1,857 Cumulative repurchased through July 1, 2022 447 16,324 Repurchased in fiscal year 2023 (1) 6 444 Cumulative repurchased through June 30, 2023 453 16,768 Repurchased in fiscal year 2024 (1) 1 38 Cumulative repurchased through June 28, 2024 454 $ 16,806 ___________________________________________________ (1) For fiscal years 2024, 2023 and 2022, includes net share settle ments of $38 million, $44 million and $51 million for 1 million, 1 million a nd 1 million shares, respectively, in connection with tax withholding related to vesting of restricted share units.

Share-based Compensation (Table

Share-based Compensation (Tables)	12 Months Ended
	Jun. 28, 2024
Share-Based Payment Arrangement [Abstract]
Nonvested share activity	The following is a summary of unvested restricted stock activities: Unvested Restricted Stocks Number of Shares (In millions) Weighted-Average Grant-Date Fair Value Unvested at June 30, 2023 3.7 $ 62.07 Granted 2.0 $ 59.96 Forfeited (0.5) $ 62.80 Vested (1.8) $ 59.25 Unvested at June 28, 2024 3.4 $ 62.20
Weighted-average assumptions used to determine the fair value	The fair value related to RSUs for fiscal years 2024, 2023 and 2022 were estimated using the following assumptions: Fiscal Years 2024 2023 2022 RSUs Expected term (in years) 1 - 2.2 1 - 2.2 1 - 2.5 Expected dividend rate 2.4 - 4.4% 3.2 - 5.5% 2.4 - 3.4% Weighted-average expected dividend rate 4.0 % 3.8 % 2.8 % Weighted-average fair value $ 59.96 $ 62.82 $ 82.4

Guarantees (Tables)

Guarantees (Tables)	12 Months Ended
	Jun. 28, 2024
Guarantees [Abstract]
Schedule of Product Warranty Liability	Changes in the Company’s product warranty liability during the fiscal years ended June 28, 2024, June 30, 2023 and July 1, 2022 were as follows: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Balance, beginning of period $ 168 $ 148 $ 136 Warranties issued 53 55 79 Repairs and replacements (81) (92) (88) Changes in liability for pre-existing warranties, including expirations 9 57 21 Balance, end of period $ 149 $ 168 $ 148

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Jun. 28, 2024
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted net income (loss) per share	The following table sets forth the computation of basic and diluted net (loss) income per share attributable to the shareholders of the Company: Fiscal Years Ended (In millions, except per share data) June 28, June 30, July 1, Numerator: Net income (loss) $ 335 $ (529) $ 1,649 Number of shares used in per share calculations: Total shares for purposes of calculating basic net income (loss) per share 209 207 220 Weighted-average effect of dilutive securities: Employee equity award plans 2 — 4 2028 Notes if-converted shares 1 — — Total shares for purposes of calculating diluted net income (loss) per share 212 207 224 Net income (loss) per share Basic $ 1.60 $ (2.56) $ 7.50 Diluted 1.58 (2.56) 7.36

Business Segment and Geograph_2

Business Segment and Geographic Information (Tables)	12 Months Ended
	Jun. 28, 2024
Segment Reporting [Abstract]
Summary of Operations by Geographic Area	The following table summarizes the Company’s long-lived assets by country: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Long-lived assets: United States $ 658 $ 667 $ 670 Thailand 574 606 679 Singapore 447 460 557 Other 338 369 426 Consolidated $ 2,017 $ 2,102 $ 2,332

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Jun. 28, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table provides information about disaggregated revenue by sales channel and country for the Company’s single reportable segment: Fiscal Years Ended (Dollars in millions) June 28, June 30, July 1, Revenues by Channel OEMs $ 4,896 $ 5,448 $ 8,742 Distributors 972 1,119 1,676 Retailers 683 817 1,243 Total $ 6,551 $ 7,384 $ 11,661 Revenue from external customers (1) : Singapore $ 3,429 $ 3,271 $ 5,322 United States 2,308 3,053 4,694 The Netherlands 802 1,046 1,627 Other 12 14 18 Total $ 6,551 $ 7,384 $ 11,661

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022	Sep. 29, 2023
Schedule of Fiscal Years [Line Items]
Increase to net income	$ 335	$ (529)	$ 1,649
Decrease in diluted earnings per share (in dollars per share)	$ (1.58)	$ 2.56	$ (7.36)
Advertising Expense
Advertising costs	$ 18	$ 30	$ 34
Government grants recognized in period	$ 3	$ 13
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of revenue	Cost of revenue
Government Assistance, Advanced Cash Grant	$ 17	$ 13
Other Long-Lived Assets Policy Update
Schedule of Fiscal Years [Line Items]
Increase to net income	$ 99
Decrease in diluted earnings per share (in dollars per share)	$ 0.47
Minimum
Establishment of Warranty Accruals
Product warranty period term (in years)	1 year
Minimum | Manufacturing Equipment
Advertising Expense
Useful life in years		3 years		3 years
Maximum
Establishment of Warranty Accruals
Product warranty period term (in years)	5 years
Maximum | Manufacturing Equipment
Advertising Expense
Useful life in years		7 years		10 years

Balance Sheet Information (Narr

Balance Sheet Information (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Property, Equipment and Leasehold Improvements, net
Restricted cash and cash equivalents, current	$ 2	$ 2	$ 2
Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale	0	0
Debt Securities, Available-for-Sale, Allowance for Credit Loss	0	0
Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount	1,200	876
Continuing Involvement with Continued to be Recognized Transferred Financial Assets, Amount Outstanding	294	275
Discount on trade receivables sold	11	11
Depreciation Expense	264	504	431
Accelerated depreciation charge	13	85
Capitalized Interest	$ 9	8	$ 3
Operating Expense
Property, Equipment and Leasehold Improvements, net
Accelerated depreciation charge		25
Cost of Sales
Property, Equipment and Leasehold Improvements, net
Accelerated depreciation charge		$ 60

Balance Sheet Information (Cash

Balance Sheet Information (Cash, Cash Equivalents, and Restricted Cash) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Investments, Debt and Equity Securities [Abstract]
Cash and cash equivalents	$ 1,358	$ 786	$ 615
Restricted cash included in Other current assets	2	2	2
Total cash, cash equivalents, and restricted cash shown in the Statements of Cash Flows	$ 1,360	$ 788	$ 617	$ 1,211

Balance Sheet Information (Acco

Balance Sheet Information (Accounts Receivable, net) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts Receivable, Gross, Current	$ 433	$ 625
Allowance for Doubtful Accounts Receivable, Current	(4)	(4)
Accounts receivable, net	429	621
Continuing Involvement with Continued to be Recognized Transferred Financial Assets, Amount Outstanding	$ 294	$ 275

Balance Sheet Information (Allo

Balance Sheet Information (Allowance for Doubtful Accounts Rollforward) (Details) - Allowance for doubtful accounts - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 4	$ 4	$ 4
Charges to Operations	0	0	0
Balance at End of Period	$ 4	$ 4	$ 4

Balance Sheet Information (Inve

Balance Sheet Information (Inventories) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Inventory, Net [Abstract]
Raw materials and components	$ 270	$ 241
Work-in-process	831	682
Finished goods	138	217
Total Inventory	$ 1,239	$ 1,140

Balance Sheet Information (Othe

Balance Sheet Information (Other Current Assets) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Schedule of Investments [Abstract]
Vendor receivables	$ 110	$ 167
Other current assets	196	191
Total	$ 306	$ 358

Balance Sheet Information (Prop

Balance Sheet Information (Property, Equipment and Leasehold Improvements, net) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 10,260	$ 10,267
Less: accumulated depreciation and amortization	(8,646)	(8,561)
Total property, equipment and leasehold improvements, net	1,614	1,706
Land
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	18	21
Equipment
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 8,632	8,504
Equipment | Minimum
Property, Equipment and Leasehold Improvements, net
Useful life in years	3 years
Equipment | Maximum
Property, Equipment and Leasehold Improvements, net
Useful life in years	10 years
Buildings and leasehold improvements
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 1,412	1,435
Buildings and leasehold improvements | Maximum
Property, Equipment and Leasehold Improvements, net
Useful life in years	30 years
Construction in progress
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 198	$ 307

Balance Sheet Information (Accr

Balance Sheet Information (Accrued Expenses) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Payables and Accruals [Abstract]
Dividends Payable, Current	$ 147	$ 145
Other accrued expenses	507	603
Accrued expenses, total	$ 654	$ 748

Balance Sheet Information (Accu

Balance Sheet Information (Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	$ (1,199)	$ 109	$ 631
(Gains) losses reclassified into earnings	(103)	52
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	2	10
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax	0	0
Foreign currency translation adjustments	1	0	0
Other comprehensive income	(100)	62	77
Total Seagate Technology plc Shareholders' Equity, Ending Balance	(1,491)	(1,199)	109
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	98	36	(41)
Other comprehensive income before reclassifications	(11)	76
Amounts reclassified from AOCI	(89)	(14)
Other comprehensive income	(100)	62
Total Seagate Technology plc Shareholders' Equity, Ending Balance	(2)	98	36
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	103	51
Total Seagate Technology plc Shareholders' Equity, Ending Balance	0	103	51
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	(4)	(14)
Net unrealized gains arising during the period	1	11	6
Losses (gains) reclassified into earnings	1	(1)	2
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	2	10	8
Total Seagate Technology plc Shareholders' Equity, Ending Balance	(2)	(4)	(14)
Accumulated Foreign Currency Adjustment Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	(1)	(1)
Total Seagate Technology plc Shareholders' Equity, Ending Balance	$ 0	$ (1)	$ (1)

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Other intangible assets	$ 1,219	$ 1,237
Goodwill, Impaired, Accumulated Impairment Loss	0	0	$ 0
Goodwill, Translation and Purchase Accounting Adjustments	0	0	0
Disposal Group, Including Discontinued Operation, Goodwill	0	0	0
Amortization of Intangible Assets	0	$ 9	$ 20
Disposal Group, Disposed of by Sale, Not Discontinued Operations
Acquired Finite-Lived Intangible Assets [Line Items]
Other intangible assets	$ (18)

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($)

12 Months Ended

Oct. 14, 2021

Jun. 28, 2024

Jun. 30, 2023

Jul. 01, 2022

Sep. 13, 2023

May 30, 2023

Nov. 30, 2022

Aug. 18, 2022

Dec. 08, 2020

Jun. 18, 2020

Jun. 10, 2020

May 14, 2015

Dec. 02, 2014

May 28, 2014

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.50%

9.625%

Current portion of long-term debt

$ (479,000,000)

$ (63,000,000)

Long-term debt, less current portion

5,195,000,000

5,388,000,000

Net (loss) gain from early redemption of debt

(29,000,000)

190,000,000

$ 0

Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Reported Value Measurement

Debt Instrument [Line Items]

Long-Term Debt, Gross

5,704,000,000

5,487,000,000

Debt Issuance Costs, Net

(30,000,000)

(36,000,000)

Debt, net of debt issuance costs

5,674,000,000

5,451,000,000

Current portion of long-term debt

(479,000,000)

(63,000,000)

Long-term debt, less current portion

$ 5,195,000,000

5,388,000,000

4.750% Senior Notes due June 2023 | Reported Value Measurement

Debt Instrument [Line Items]

Stated interest rate (as a percent)

4.75%

4.875% Senior Notes due March 2024 | Reported Value Measurement

Debt Instrument [Line Items]

Stated interest rate (as a percent)

4.875%

4.75% Senior Notes due January 2025

Debt Instrument [Line Items]

Stated interest rate (as a percent)

4.75%

4.75% Senior Notes due January 2025 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 479,000,000

479,000,000

Stated interest rate (as a percent)

4.75%

4.875% Senior Notes due June 2027 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 505,000,000

504,000,000

Stated interest rate (as a percent)

4.875%

4.091% Senior Notes due June 2029 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 471,000,000

465,000,000

Stated interest rate (as a percent)

4.091%

3.125% Senior Notes due July 2029

Debt Instrument [Line Items]

Stated interest rate (as a percent)

3.125%

3.125% Senior Notes due July 2029 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 163,000,000

163,000,000

Stated interest rate (as a percent)

3.125%

4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Stated interest rate (as a percent)

4.125%

4.125% Senior Notes due January 2031 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 275,000,000

275,000,000

Stated interest rate (as a percent)

4.125%

3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Stated interest rate (as a percent)

3.375%

3.375% Senior Notes due July 2031 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 72,000,000

72,000,000

Stated interest rate (as a percent)

3.375%

5.75% Senior Notes due December 2034

Debt Instrument [Line Items]

Stated interest rate (as a percent)

5.75%

5.75% Senior Notes due December 2034 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 489,000,000

489,000,000

Term Loan A1 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

0

430,000,000

Term Loan A2 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

0

430,000,000

SOFR Based Term Loan A3 due July 2027 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 0

430,000,000

8.25% Senior Notes due December 2029

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.25%

8.25% Senior Notes due December 2029 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 500,000,000

500,000,000

Stated interest rate (as a percent)

8.25%

8.50% Senior Notes due July 2031

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.50%

8.50% Senior Notes due July 2031 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 500,000,000

500,000,000

Stated interest rate (as a percent)

8.50%

9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Stated interest rate (as a percent)

9.625%

9.625% Senior Notes due December 2032 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 750,000,000

750,000,000

Stated interest rate (as a percent)

9.625%

Convertible Senior note 3.50 percent due June 2028

Debt Instrument [Line Items]

Stated interest rate (as a percent)

3.50%

Convertible Senior note 3.50 percent due June 2028 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 1,500,000,000

0

Convertible Debt

$ 1,500,000,000

$ 0

Senior Notes | 4.75% Senior Notes due January 2025

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | 4.875% Senior Notes due June 2027

Debt Instrument [Line Items]

Aggregate principal amount

$ 700,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | 4.091% Senior Notes due June 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.091%

Senior Notes | 3.125% Senior Notes due July 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

3.125%

Senior Notes | 4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.125%

Senior Notes | 3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

8.50%

3.375%

Senior Notes | 5.75% Senior Notes due December 2034

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

5.75%

Senior Notes | 8.25% Senior Notes due December 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

8.25%

Senior Notes | 8.50% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Senior Notes | 9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Aggregate principal amount

$ 750,000,000

Term Loan A1 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Convertible Debt | Convertible Senior note 3.50 percent due June 2028

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,500,000,000

Stated interest rate (as a percent)

3.50%

Minimum | Term Loan A1

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.125%

Minimum | Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.25%

Maximum | Term Loan A1

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.375%

Maximum | Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.50%

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)

12 Months Ended

Oct. 14, 2021

Jun. 28, 2024

Jun. 30, 2023

Jul. 01, 2022

Sep. 13, 2023

May 30, 2023

Nov. 30, 2022

Aug. 18, 2022

Dec. 08, 2020

Jun. 18, 2020

Jun. 10, 2020

May 14, 2015

May 28, 2014

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.50%

9.625%

Net (loss) gain from early redemption of debt

$ (29,000,000)

$ 190,000,000

$ 0

Net loss (gain) from redemption and repurchase of debt

$ (7,000,000)

$ 204,000,000

$ 0

Capped Call Transaction, Price Per Share

$ 107.848

Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Medium-term Notes | Debt Instrument, Leverage, Period Two

Debt Instrument [Line Items]

Debt Instrument, Covenant, Interest Coverage Ratio, Maximum

2.25

Debt Instrument, Covenant, Interest Coverage Ratio, Minimum

1

Medium-term Notes | Debt Instrument, Leverage, Period Three

Debt Instrument [Line Items]

Debt Instrument, Covenant, Interest Coverage Ratio, Maximum

3.25

Debt Instrument, Covenant, Interest Coverage Ratio, Minimum

1

4.75% Senior Notes due January 2025

Debt Instrument [Line Items]

Stated interest rate (as a percent)

4.75%

9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Stated interest rate (as a percent)

9.625%

4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Stated interest rate (as a percent)

4.125%

3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Stated interest rate (as a percent)

3.375%

8.50% Senior Notes due July 2031

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.50%

Senior note 3.50 percent due June 2028

Debt Instrument [Line Items]

Percentage of principal amount redeemed

100%

Debt Instrument, Redemption, Principal Outstanding

$ 150,000,000

Senior note 3.50 percent due June 2028 | Maximum

Debt Instrument [Line Items]

Percentage of principal amount redeemed

130%

Convertible Senior note 3.50 percent due June 2028

Debt Instrument [Line Items]

Stated interest rate (as a percent)

3.50%

Senior Notes | 4.75% Senior Notes due January 2025

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | 4.091% Senior Notes due June 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.091%

Senior Notes | 4.875% Senior Notes due June 2027

Debt Instrument [Line Items]

Aggregate principal amount

$ 700,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | 9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Aggregate principal amount

$ 750,000,000

Senior Notes | 4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.125%

Senior Notes | 3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

8.50%

3.375%

Senior Notes | 8.50% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Term Loan A1 | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.125%

Term Loan A1 | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.375%

Term Loan A1 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Term Loan A2 | Medium-term Notes | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.25%

Term Loan A2 | Medium-term Notes | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.50%

Tenth Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Two

Debt Instrument [Line Items]

Leverage ratio, maximum

6.75

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

Debt Instrument, Covenant, Leverage Ratio, Aggregate Revolving Commitments Minimum

0.25

Tenth Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Three

Debt Instrument [Line Items]

Leverage ratio, maximum

4

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

Terms Loans A1, A2 and A3

Debt Instrument [Line Items]

Net (loss) gain from early redemption of debt

$ (29,000,000)

Convertible Debt | Senior note 3.50 percent due June 2028

Debt Instrument [Line Items]

Debt Instrument, Over Allotment Option, Amount

$ 200,000,000

Convertible Debt | Convertible Senior note 3.50 percent due June 2028

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,500,000,000

Stated interest rate (as a percent)

3.50%

Interest Expense, Debt

$ 25,000,000

Debt Instrument, Interest Rate, Effective Percentage

3.94%

Debt (Future principal payments

Debt (Future principal payments on long-term debt) (Details) $ in Millions	Jun. 28, 2024 USD ($)
Debt Disclosure [Abstract]
2025	$ 479
2026	0
2027	505
2028	1,500
2029	495
Thereafter	2,750
Total future principal payments on short-term and long-term debt	$ 5,729

Income Taxes (Income (Loss) Bef

Income Taxes (Income (Loss) Before Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Income Tax Disclosure [Abstract]
U.S.	$ 249	$ 300	$ 145
Non-U.S.	196	(796)	1,534
Income (loss) before income taxes	$ 445	$ (496)	$ 1,679

Income Taxes (Schedule of Provi

Income Taxes (Schedule of Provision for (Benefit From) Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Current income tax expense:
U.S.	$ 2	$ 6	$ 4
Non-U.S.	30	17	35
Total Current	32	23	39
Deferred income tax expense/(benefit):
U.S.	71	9	3
Non-U.S.	7	1	(12)
Total Deferred	78	10	(9)
Provision for income taxes	$ 110	$ 33	$ 30

Income Taxes (Schedule of Defer

Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Deferred tax assets
Accrued warranty	$ 37	$ 38
Inventory carrying value adjustments	32	40
Receivable allowances	9	11
Accrued compensation and benefits	36	43
Capitalized research expenses	0	119
Depreciation	19	40
Restructuring accruals	2	14
Lease liabilities	64	62
Other accruals and deferred items	11	14
Net operating losses	613	542
Tax credit carryforwards	593	619
Deferred Tax Assets, Capital Loss Carryforwards	67	0
Other assets	40	1
Gross: Deferred tax assets	1,523	1,543
Less: Valuation allowance	(430)	(370)
Net: Deferred tax assets	1,093	1,173
Deferred tax liabilities
Unremitted earnings of certain non-U.S. entities	(4)	(4)
Acquisition-related items	(1)	(1)
Right-of-use assets	(63)	(62)
Other liabilities	0	(2)
Net: Deferred tax liabilities	68	69
Total net deferred tax assets	$ 1,025	$ 1,104

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Total net deferred tax assets	$ 1,025	$ 1,104
Increase (decrease) in valuation allowance	(60)
Operating loss carryforwards, subject to expiration	4
Tax credit carryforward subject to expiration	22
NOL subject to annual limitation on use	17
Tax credit carryforwards subject to annual limitation on use	$ 18
Domestic federal statutory rate (as a percent)	17%	25%	25%
Income tax holiday, aggregate dollar amount	$ 40	$ 14	$ 290
Income tax holiday tax incentive income tax benefits per share (in dollars per share)	$ 0.19	$ 0.07	$ 1.29
Total gross unrecognized tax benefits excluding interest and penalties	$ 112	$ 116	$ 114	$ 108
U.S. Federal
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Net operating loss carryforwards	3,700
Tax credit carryforwards	709
Capital loss carryforward	294
Non-U.S.
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Net operating loss carryforwards	$ 411

Income Taxes (Schedule of Recon

Income Taxes (Schedule of Reconciliation Between Income at Statutory Rate and Effective Rate) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Income Tax Disclosure [Abstract]
Domestic federal statutory rate (as a percent)	17%	25%	25%
Provision (benefit) at statutory rate	$ 76	$ (124)	$ 420
Permanent differences	5	8	5
Valuation allowance	47	(18)	7
Effect of rates different than statutory	(2)	178	(371)
Research credit	(9)	(18)	(26)
Capital loss carryforward	(11)	0	0
Other individually immaterial items	4	7	(5)
Provision for income taxes	$ 110	$ 33	$ 30

Income Taxes (Schedule of Gross

Income Taxes (Schedule of Gross Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Income Tax Disclosure [Abstract]
Balance of unrecognized tax benefits at the beginning of the year	$ 116	$ 114	$ 108
Gross increase for tax positions of prior years	3	0	1
Gross decrease for tax positions of prior years	(12)	(4)	(1)
Gross increase for tax positions of current year	5	7	6
Gross decrease for tax positions of current year	0	(1)	0
Balance of unrecognized tax benefits at the end of the year	$ 112	$ 116	$ 114

Leases, Codification Topic 84_2

Leases, Codification Topic 842 (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Leases [Abstract]
Gain on sale-leaseback transactions	$ 30	$ 156
ROU assets obtained	$ 47	$ 353

Leases, Codification Topic 84_3

Leases, Codification Topic 842 (Operating Lease Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Leases [Abstract]
Operating Lease, Cost	$ 72	$ 21	$ 16
Variable Lease, Cost	3	3	4
Lease, Cost	75	24	20
Operating Lease, Payments	$ 63	$ 23	$ 20

Leases, Codification Topic 84_4

Leases, Codification Topic 842 (Weighted-Average, ROU Assets, and Lease Liabilities) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Leases [Abstract]
Operating Lease, Weighted Average Remaining Lease Term	8 years 7 months 6 days	9 years 7 months 6 days	9 years 3 months 18 days
Operating Lease, Weighted Average Discount Rate, Percent	8.45%	8.49%	6.40%
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Total Assets	Total Assets
Operating lease, ROU asset	$ 403	$ 396
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses	Accrued expenses
Operating Lease, Liability, Current	$ 61	$ 51
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities
Operating Lease, Liability, Noncurrent	$ 338	$ 333

Leases, Codification Topic 84_5

Leases, Codification Topic 842 (Future Minimum Lease Payments) (Details) $ in Millions	Jun. 28, 2024 USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One	$ 63
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two	64
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three	59
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four	60
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five	62
Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five	256
Lessee, Operating Lease, Liability, to be Paid	564
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(165)
Operating lease liability	$ 399

Restructuring and Exit Costs (N

Restructuring and Exit Costs (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Restructuring Reserve [Line Items]
Restructuring and other, net	$ (30)	$ 102	$ 3
Restructuring Reserve	4	119	5	$ 8
Gain on sale of assets	31	167
Proceeds from the sale of assets	40	534	0
Gain on sale-leaseback transactions	30	156
Workforce Restructuring Charges
Restructuring Reserve [Line Items]
Restructuring and other, net	7	269	$ 3
Sale and Leaseback of Property
Restructuring Reserve [Line Items]
Proceeds from the sale of assets	$ 34
Accrued Liabilities [Member] | Workforce Restructuring Charges
Restructuring Reserve [Line Items]
Restructuring Reserve		$ 117

Restructuring and Exit Costs (S

Restructuring and Exit Costs (Schedule of Restructuring Reserve by Type of Cost) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Restructuring Reserve [Roll Forward]
Restructuring Reserve	$ 4	$ 119	$ 5	$ 8
Restructuring and other, net	(30)	102	3
Payments for Restructuring	(116)	(155)	(6)
Restructuring Reserve, Accrual Adjustment	(6)	0
Restructuring and Related Cost, Incurred Cost	336
Restructuring and Related Cost, Expected Cost	$ 0
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Restructuring and other, net
Employee Severance | April 2023 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	$ 1	108	0	0
Restructuring and other, net	0	145	0
Payments for Restructuring	(106)	(37)	0
Restructuring Reserve, Accrual Adjustment	(1)	0
Restructuring and Related Cost, Incurred Cost	144
Restructuring and Related Cost, Expected Cost	0
Employee Severance | October 2022 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	0	1	0	0
Restructuring and other, net	0	104	0
Payments for Restructuring	(1)	(103)	0
Restructuring Reserve, Accrual Adjustment	0	0
Restructuring and Related Cost, Incurred Cost	104
Restructuring and Related Cost, Expected Cost	0
Employee Severance | Other Plans
Restructuring Reserve [Roll Forward]
Restructuring Reserve	2	1	0	2
Restructuring and other, net	6	10	2
Payments for Restructuring	(5)	(10)	(4)
Restructuring Reserve, Accrual Adjustment	0	1
Restructuring and Related Cost, Incurred Cost	70
Restructuring and Related Cost, Expected Cost	0
Facility Closing | April 2023 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	0	0	0	0
Restructuring and other, net	0	3	0
Payments for Restructuring	0	(3)	0
Restructuring Reserve, Accrual Adjustment	0	0
Restructuring and Related Cost, Incurred Cost	3
Restructuring and Related Cost, Expected Cost	0
Facility Closing | October 2022 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	1	5	0	0
Restructuring and other, net	0	7	0
Payments for Restructuring	(3)	(1)	0
Restructuring Reserve, Accrual Adjustment	(1)	(1)
Restructuring and Related Cost, Incurred Cost	5
Restructuring and Related Cost, Expected Cost	0
Facility Closing | Other Plans
Restructuring Reserve [Roll Forward]
Restructuring Reserve	0	4	5	$ 6
Restructuring and other, net	1	0	1
Payments for Restructuring	(1)	(1)	(2)
Restructuring Reserve, Accrual Adjustment	(4)	0
Restructuring and Related Cost, Incurred Cost	10
Restructuring and Related Cost, Expected Cost	0
Workforce Restructuring Charges
Restructuring Reserve [Roll Forward]
Restructuring and other, net	$ 7	269	$ 3
Workforce Restructuring Charges | Accrued Liabilities [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve		117
Workforce Restructuring Charges | Other Noncurrent Liabilities
Restructuring Reserve [Roll Forward]
Restructuring Reserve		$ 2

Derivative Financial Instrume_3

Derivative Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Derivative Financial Instruments
Derivative notional amount	$ 312	$ 2,038
Cash Flow Hedging
Derivative Financial Instruments
Unrealized Gain (Loss) on Cash Flow Hedging Instruments	0	12
Term Loan
Derivative Financial Instruments
Derivative, notional amount		1,288
Total Return Swap | Not Designated as Hedging Instrument
Derivative Financial Instruments
Derivative notional amount	112	$ 108
Interest Rate Swap
Derivative Financial Instruments
Proceeds from counterparty	25
Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax	$ 6

Derivative Financial Instrume_4

Derivative Financial Instruments (Schedule of gross fair value of derivative instruments) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	$ 1	$ 23
Liability derivatives, Accrued expenses	(1)	(11)
Derivative notional amount	312	2,038
Term Loan
Fair Values of Derivative Instruments
Derivative, notional amount		1,288
Derivatives designated as hedging instruments | Foreign currency forward exchange contracts
Fair Values of Derivative Instruments
Derivative notional amount	35	445
Derivatives designated as hedging instruments | Foreign currency forward exchange contracts | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	0	2
Derivatives designated as hedging instruments | Foreign currency forward exchange contracts | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	(1)	(10)
Derivatives designated as hedging instruments | Interest Rate Swap | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets		20
Derivatives designated as hedging instruments | Interest Rate Swap | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses		0
Not Designated as Hedging Instrument | Foreign currency forward exchange contracts
Fair Values of Derivative Instruments
Derivative notional amount	165	197
Not Designated as Hedging Instrument | Foreign currency forward exchange contracts | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	1	0
Not Designated as Hedging Instrument | Foreign currency forward exchange contracts | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	0	(1)
Not Designated as Hedging Instrument | Total Return Swap
Fair Values of Derivative Instruments
Derivative notional amount	112	108
Not Designated as Hedging Instrument | Total Return Swap | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	0	1
Not Designated as Hedging Instrument | Total Return Swap | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	$ 0	$ 0

Derivative Financial Instrume_5

Derivative Financial Instruments (Schedule of the effect of derivative instruments on Other comprehensive income (loss) and the Consolidated Statement of Operations) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Other nonoperating income, net | Foreign currency forward exchange contracts
Derivatives Instruments, Gain (Loss)
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	$ (8)	$ (7)
Gain recognized on derivatives	2	(6)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(3)	(16)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Ineffective Portion, Net	3	(4)
Operating Expense | Total Return Swap
Derivatives Instruments, Gain (Loss)
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net	10	6
Operating Expense | Interest Rate Swap
Derivatives Instruments, Gain (Loss)
Gain recognized on derivatives	(15)	71
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(11)	29
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Ineffective Portion, Net	$ 104	$ 0

Fair Value (Narrative) (Details

Fair Value (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 28, 2024	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Assets and liabilities measured at fair value on a recurring basis
Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale		$ 0	$ 0
Income (Loss) from Equity Method Investments		(29)	(4)	$ 8
Equity Method Investments	$ 12	12	55
Net gains (losses) from investment under measurement alternative		(24)	(5)	$ 4
Equity Securities without Readily Determinable Fair Value, Amount	65	65	88
Debt Securities, Available-for-Sale, Allowance for Credit Loss	0	0	0
Amortized cost, due in 1 to 5 years	15	15
Proceeds from Sale of Equity Method Investments	$ 14
Significant Unobservable Inputs (Level 3) | Recurring basis
Assets and liabilities measured at fair value on a recurring basis
Other Assets, Fair Value Disclosure			$ 16
Other nonoperating income, net
Assets and liabilities measured at fair value on a recurring basis
Downward adjustments		$ 25

Fair Value (Schedule of Fair Va

Fair Value (Schedule of Fair Value, by Balance Sheet Grouping, Measured on Recurring Basis) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023
Assets:
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued expenses	Accrued expenses
Recurring basis
Assets:
Cash and cash equivalents and short-term investments	$ 386	$ 72
Total assets	404	113
Liabilities:
Financial and Nonfinancial Liabilities, Fair Value Disclosure	(1)	(11)
Recurring basis | Derivative Financial Instruments, Assets
Assets:
Derivative asset	1	23
Recurring basis | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	(1)	(11)
Recurring basis | Money market funds
Assets:
Cash and cash equivalents and short-term investments	386	72
Restricted Cash and Investments, Current	1	1
Recurring basis | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	1	1
Recurring basis | Debt Securities
Assets:
Restricted Cash and Investments, Current	15	16
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1)
Assets:
Cash and cash equivalents and short-term investments	386	72
Total assets	387	73
Liabilities:
Financial and Nonfinancial Liabilities, Fair Value Disclosure	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Derivative Financial Instruments, Assets
Assets:
Derivative asset	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Money market funds
Assets:
Cash and cash equivalents and short-term investments	386	72
Restricted Cash and Investments, Current	1	1
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Debt Securities
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Other Observable Inputs (Level 2)
Assets:
Cash and cash equivalents and short-term investments	0	0
Total assets	2	24
Liabilities:
Financial and Nonfinancial Liabilities, Fair Value Disclosure	(1)	(11)
Recurring basis | Significant Other Observable Inputs (Level 2) | Derivative Financial Instruments, Assets
Assets:
Derivative asset	1	23
Recurring basis | Significant Other Observable Inputs (Level 2) | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	(1)	(11)
Recurring basis | Significant Other Observable Inputs (Level 2) | Money market funds
Assets:
Cash and cash equivalents and short-term investments	0	0
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Other Observable Inputs (Level 2) | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	1	1
Recurring basis | Significant Other Observable Inputs (Level 2) | Debt Securities
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Unobservable Inputs (Level 3)
Assets:
Cash and cash equivalents and short-term investments	0	0
Total assets	15	16
Liabilities:
Financial and Nonfinancial Liabilities, Fair Value Disclosure	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Derivative Financial Instruments, Assets
Assets:
Derivative asset	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Money market funds
Assets:
Cash and cash equivalents and short-term investments	0	0
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Debt Securities
Assets:
Restricted Cash and Investments, Current	$ 15	$ 16

Fair Value (Schedule of Carryin

Fair Value (Schedule of Carrying Values and Estimated Fair Values of Debt Instruments) (Details) - USD ($) $ in Millions	Jun. 28, 2024	Jun. 30, 2023	May 30, 2023	Nov. 30, 2022
Debt Fair Value Disclosures
Less: current portion of debt, net of debt issuance costs	$ (479)	$ (63)
Long-term debt, less current portion, net of debt issuance costs	$ 5,195	5,388
Stated interest rate (as a percent)			8.50%	9.625%
4.75% Senior Notes due January 2025
Debt Fair Value Disclosures
Stated interest rate (as a percent)	4.75%
3.125% Senior Notes due July 2029
Debt Fair Value Disclosures
Stated interest rate (as a percent)	3.125%
8.25% Senior Notes due December 2029
Debt Fair Value Disclosures
Stated interest rate (as a percent)	8.25%
4.125% Senior Notes due January 2031
Debt Fair Value Disclosures
Stated interest rate (as a percent)	4.125%
3.375% Senior Notes due July 2031
Debt Fair Value Disclosures
Stated interest rate (as a percent)	3.375%
8.50% Senior Notes due July 2031
Debt Fair Value Disclosures
Stated interest rate (as a percent)	8.50%
9.625% Senior Notes due December 2032
Debt Fair Value Disclosures
Stated interest rate (as a percent)	9.625%
5.75% Senior Notes due December 2034
Debt Fair Value Disclosures
Stated interest rate (as a percent)	5.75%
Convertible Senior note 3.50 percent due June 2028
Debt Fair Value Disclosures
Stated interest rate (as a percent)	3.50%
Senior note 4.875 percent due June 2027
Debt Fair Value Disclosures
Stated interest rate (as a percent)	4.875%
Senior note 4.091 percent due June 2029
Debt Fair Value Disclosures
Stated interest rate (as a percent)	4.091%
Carrying Amount
Debt Fair Value Disclosures
Debt issuance costs	$ (30)	(36)
Debt, net of debt issuance costs	5,674	5,451
Less: current portion of debt, net of debt issuance costs	(479)	(63)
Long-term debt, less current portion, net of debt issuance costs	5,195	5,388
Long-Term Debt, Gross	$ 5,704	5,487
Carrying Amount | 4.750% Senior Notes due June 2023
Debt Fair Value Disclosures
Stated interest rate (as a percent)	4.75%
Carrying Amount | 4.875% Senior Notes due March 2024
Debt Fair Value Disclosures
Stated interest rate (as a percent)	4.875%
Carrying Amount | 4.75% Senior Notes due January 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 479	479
Stated interest rate (as a percent)	4.75%
Carrying Amount | 4.875% Senior Notes due June 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 505	504
Stated interest rate (as a percent)	4.875%
Carrying Amount | 4.091% Senior Notes due June 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 471	465
Stated interest rate (as a percent)	4.091%
Carrying Amount | 3.125% Senior Notes due July 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 163	163
Stated interest rate (as a percent)	3.125%
Carrying Amount | 8.25% Senior Notes due December 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 500	500
Stated interest rate (as a percent)	8.25%
Carrying Amount | 4.125% Senior Notes due January 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 275	275
Stated interest rate (as a percent)	4.125%
Carrying Amount | 3.375% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 72	72
Stated interest rate (as a percent)	3.375%
Carrying Amount | 8.50% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 500	500
Stated interest rate (as a percent)	8.50%
Carrying Amount | 9.625% Senior Notes due December 2032
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 750	750
Stated interest rate (as a percent)	9.625%
Carrying Amount | 5.75% Senior Notes due December 2034
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 489	489
Carrying Amount | SOFR Based Term Loan A1 due September 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0	430
Carrying Amount | SOFR Based Term Loan A2 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0	430
Carrying Amount | SOFR Based Term Loan A3 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 0	430
Carrying Amount | Senior Notes 5.750 Percent due December 2034
Debt Fair Value Disclosures
Stated interest rate (as a percent)	5.75%
Carrying Amount | Convertible Senior note 3.50 percent due June 2028
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 1,500	0
Estimate of Fair Value Measurement
Debt Fair Value Disclosures
Debt issuance costs	0	0
Debt, net of debt issuance costs	6,342	5,371
Less: current portion of debt, net of debt issuance costs	(476)	(62)
Long-term debt, less current portion, net of debt issuance costs	5,866	5,309
Long-Term Debt, Gross	6,342	5,371
Estimate of Fair Value Measurement | 4.75% Senior Notes due January 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	476	472
Estimate of Fair Value Measurement | 4.875% Senior Notes due June 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	493	484
Estimate of Fair Value Measurement | 4.091% Senior Notes due June 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	459	436
Estimate of Fair Value Measurement | 3.125% Senior Notes due July 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	139	126
Estimate of Fair Value Measurement | 8.25% Senior Notes due December 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	537	522
Estimate of Fair Value Measurement | 4.125% Senior Notes due January 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	245	227
Estimate of Fair Value Measurement | 3.375% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	58	53
Estimate of Fair Value Measurement | 8.50% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	538	524
Estimate of Fair Value Measurement | 9.625% Senior Notes due December 2032
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	855	830
Estimate of Fair Value Measurement | 5.75% Senior Notes due December 2034
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	472	438
Estimate of Fair Value Measurement | SOFR Based Term Loan A1 due September 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0	426
Estimate of Fair Value Measurement | SOFR Based Term Loan A2 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0	420
Estimate of Fair Value Measurement | SOFR Based Term Loan A3 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0	413
Estimate of Fair Value Measurement | Convertible Senior note 3.50 percent due June 2028
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 2,070	$ 0

Shareholders' Equity (Narrative

Shareholders' Equity (Narrative) (Details)	Jun. 28, 2024 USD ($) $ / shares shares
Equity [Abstract]
Authorized Share Capital Common and Preferred Stock Value | $	$ 13,500
Ordinary shares, authorized (in shares)	1,250,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.00001
Ordinary shares, outstanding (in shares)	210,182,269
Preferred shares, authorized (in shares)	100,000,000
Preferred shares, par value (in dollars per share) | $ / shares	$ 0.00001
Preferred Stock, Shares Issued	0
Preferred stock, shares outstanding (in shares)	0
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $	$ 1,900,000,000

Shareholders' Equity (Schedule

Shareholders' Equity (Schedule of Share Repurchases) (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023		Jul. 01, 2022
Repurchases of Equity Securities, Number of Shares Repurchased
Number of shares repurchased, cumulative, beginning of the period (in shares)	453	447		426
Number of shares repurchased, during the period (in shares)	1	6	[1]	21	[1]
Number of shares repurchased, cumulative, end of the period (in shares)	454	453		447
Repurchases of Equity Securities, Dollar Value of Shares Repurchased
Dollar value of shares repurchased, cumulative, beginning of the period	$ 16,768	$ 16,324		$ 14,467
Dollar value of shares repurchased during the period	38	444	[1]	1,857	[1]
Dollar value of shares repurchased, cumulative, end of the period	16,806	16,768		16,324
Settlement in connection with tax withholding	$ 38	$ 44		$ 51
Settlement of shares in connection with tax withholding (in shares)	1	1		1
[1] For fiscal years 2024, 2023 and 2022, includes net share settle ments of $38 million, $44 million and $51 million for 1 million, 1 million a nd 1 million shares, respectively, in connection with tax withholding related to vesting of restricted share units.

Share-based Compensation (Narra

Share-based Compensation (Narrative) (Details)	12 Months Ended
	Jun. 28, 2024 USD ($) mo $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jul. 01, 2022 USD ($) $ / shares shares	Oct. 20, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Tax benefit | $	$ 5,000,000	$ 5,000,000	$ 15,000,000
Share-based compensation | $	$ 127,000,000	115,000,000	145,000,000
Percentage match of employee contribution under 401(k) plan (as a percent)	50%
Maximum contribution match by the employer as a percentage of employee compensation (as a percent)	6%
Maximum amount of contribution per employee made by the employer per year | $	$ 6,000
Matching contributions | $	$ 65,000,000	$ 79,000,000	$ 85,000,000
Per share weighted average price of shares purchased (in dollars per share) | $ / shares	$ 54.71	$ 62.36	$ 64.85
Shares purchased in period (in shares)	1,000,000	1,000,000	1,000,000
Stock Compensation Plan | STX 2012 EIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant	9,600,000
Stock Compensation Plan | Equity Incentive Plan 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized				14,100,000
Employee Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant	5,800,000
Number of shares authorized	60,000,000
Offering period for Stock Purchase Plan (in months)	6 months
Maximum number of shares per offering period	1,500,000
Employee purchase price, percentage of fair market value of ordinary shares	85%
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement, Vesting Period Maximum	4 years
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	2 years 3 months 18 days
Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of options to be vested on first anniversary of vesting commencement date (as a percent)	25%
Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Two through Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of options to be vested on first anniversary of vesting commencement date (as a percent)	75%
Restricted Stock Units (RSUs) | Nonvested Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost | $	$ 152,000,000
Restricted Stock Units (RSUs) | Performance Awards Market Condition
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of nonvested shares vested | $	$ 105,000,000	$ 105,000,000	$ 96,000,000
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement, Vesting Period Maximum	4 years
Employee Stock Option | Full Value Share Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining award vesting period (in months) | mo	36
Performance Shares | TSR/ROIC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period (in years)	3 years
Restricted Stock Units and Performance Share Units | Equity Incentive Plan 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized				12,300,000

Share-based Compensation (Weigh

Share-based Compensation (Weighted-average assumptions used to determine the fair value) (Details) - Restricted Stock Units (RSUs) - $ / shares	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average expected dividend rate	4%	3.80%	2.80%
Weighted average fair value	$ 59.96	$ 62.82	$ 82.4
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	1 year	1 year	1 year
Expected dividend rate	2.40%	3.20%	2.40%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years 2 months 12 days	2 years 2 months 12 days	2 years 6 months
Expected dividend rate	4.40%	5.50%	3.40%

Share-based Compensation (Nonve

Share-based Compensation (Nonvested share activity) (Details) - Nonvested Shares - Stock Compensation Plan shares in Millions	12 Months Ended
	Jun. 28, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of shares, nonvested at the beginning of the period | shares	3.7
Number of shares, granted | shares	2
Number of shares, forfeitures | shares	(0.5)
Number of shares, vested | shares	(1.8)
Number of shares, nonvested at the end of the period | shares	3.4
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average grant-date fair value, nonvested at the beginning of the period (in dollars per share) | $ / shares	$ 62.07
Weighted-average grant-date fair value, granted (in dollars per share) | $ / shares	59.96
Weighted-average grant-date fair value, forfeitures (in dollars per share) | $ / shares	62.80
Weighted-average grant-date fair value, vested (in dollars per share) | $ / shares	59.25
Weighted-average grant-date fair value, nonvested at the end of the period (in dollars per share) | $ / shares	$ 62.20

Guarantees (Narrative) (Details

Guarantees (Narrative) (Details) - USD ($)	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Schedule of Fiscal Years [Line Items]
intellectual property indemnification obligations	$ 0
intellectual property indemnification obligations	0
Standard product warranty accrual	$ 149,000,000	$ 168,000,000	$ 148,000,000	$ 136,000,000
Minimum
Schedule of Fiscal Years [Line Items]
Product warranty period term (in years)	1 year
Maximum
Schedule of Fiscal Years [Line Items]
Product warranty period term (in years)	5 years

Guarantees (Product Warranty) (

Guarantees (Product Warranty) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance, beginning of period	$ 168	$ 148	$ 136
Warranties issued	53	55	79
Repairs and replacements	(81)	(92)	(88)
Changes in liability for pre-existing warranties, including expirations	9	57	21
Balance, end of period	$ 149	$ 168	$ 148

Earnings Per Share (Schedule of

Earnings Per Share (Schedule of computation of basic and diluted net income (loss) per share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Numerator:
Net income (loss)	$ 335	$ (529)	$ 1,649
Number of shares used in per share calculations:
Total shares for purposes of calculating basic net income per share attributable to Seagate Technology plc	209,000	207,000	220,000
Weighted-average effect of dilutive securities:
Employee equity award plans	2,000	0	4,000
Total shares for purpose of calculating diluted net income per share attributable to Seagate Technology plc	212,000	207,000	224,000
Net income per share attributable to Seagate Technology plc ordinary shareholders:
Basic net income per share (in dollars per share)	$ 1.60	$ (2.56)	$ 7.50
Diluted net income per share (in dollars per share)	$ 1.58	$ (2.56)	$ 7.36
Potential common shares excluded from the computation of diluted net income (loss) per share (in shares)		7,000
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	1,000	0	0

Commitments (Narrative) (Detail

Commitments (Narrative) (Details) $ in Millions	12 Months Ended
	Jun. 28, 2024 USD ($)
Recorded Unconditional Purchase Obligation [Line Items]
Unrecorded Unconditional Purchase Obligation	$ 56
Recorded Unconditional Purchase Obligation, Order Cancellation Fees	87
Purchase Obligation	93
Accrued Expenses
Recorded Unconditional Purchase Obligation [Line Items]
Purchase Obligation	39
Accounts Payable
Recorded Unconditional Purchase Obligation [Line Items]
Purchase Obligation	54
Inventories
Recorded Unconditional Purchase Obligation [Line Items]
Unrecorded Unconditional Purchase Obligation, Due within Two Years	31
Unrecorded Unconditional Purchase Obligation, Due within Three Years	15
Unrecorded Unconditional Purchase Obligation, Due within Four Years	7
Unrecorded Unconditional Purchase Obligation, Due within Five Years	3
Capital Addition Purchase Commitments
Recorded Unconditional Purchase Obligation [Line Items]
Unrecorded Unconditional Purchase Obligation	62
Unrecorded Unconditional Purchase Obligation, Due within Three Years	35
Unrecorded Unconditional Purchase Obligation, Due within Four Years	$ 27

Business Segment and Geograph_3

Business Segment and Geographic Information (Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas) (Details) $ in Millions	12 Months Ended
	Jun. 28, 2024 USD ($) numberOfEmployees	Jun. 30, 2023 USD ($)	Jul. 01, 2022 USD ($)
Revenue from external customers and long-lived assets
Long-lived assets	$ 2,017	$ 2,102	$ 2,332
Number of Reportable Segments | numberOfEmployees	1
Revenue from Contract with Customer Benchmark | Customer Concentration Risk [Member] | One Customer
Revenue from external customers and long-lived assets
Concentration risk, percentage of revenue	10%	10%
Singapore
Revenue from external customers and long-lived assets
Revenue	$ 3,429	$ 3,271	5,322
Long-lived assets	447	460	557
United States
Revenue from external customers and long-lived assets
Revenue	2,308	3,053	4,694
Long-lived assets	574	606	679
The Netherlands
Revenue from external customers and long-lived assets
Revenue	802	1,046	1,627
Other
Revenue from external customers and long-lived assets
Revenue	12	14	18
Long-lived assets	338	369	426
Thailand
Revenue from external customers and long-lived assets
Long-lived assets	$ 658	$ 667	$ 670

Revenue (Details)

Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 6,551	$ 7,384	$ 11,661
OEMs
Disaggregation of Revenue [Line Items]
Revenue	4,896	5,448	8,742
Distributors
Disaggregation of Revenue [Line Items]
Revenue	972	1,119	1,676
Retailers
Disaggregation of Revenue [Line Items]
Revenue	$ 683	$ 817	$ 1,243

Divesture (Details)

Divesture (Details) - USD ($) $ in Millions		12 Months Ended
	Apr. 23, 2024	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Other non-current liabilities		$ 861	$ 685
Net gain from business divestiture		313	0	$ 0
Goodwill		(1,219)	(1,237)
Operating inflow		(243)	(298)	80
Proceeds from business divestiture		326	$ 0	$ 0
Disposal Group, Disposed of by Sale, Not Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Goodwill		18
Disposal Group, Disposed of by Sale, Not Discontinued Operations | SoC Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gross consideration	$ 600
Cash consideration	560
Remaining consideration	40
Current portion of holdback amount		25
Noncurrent portion of the holdback amount		15
Other non-current liabilities		234
Net gain from business divestiture	313
Goodwill	$ 18
Operating inflow		226
Proceeds from business divestiture		$ 326

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares		12 Months Ended
	Jul. 23, 2024	Jun. 28, 2024	Jun. 30, 2023	Jul. 01, 2022
Subsequent Event [Line Items]
Cash dividends declared per ordinary share (in dollars per share)		$ 2,800,000	$ 2,800,000	$ 2,770,000
Subsequent event
Subsequent Event [Line Items]
Cash dividends declared per ordinary share (in dollars per share)	$ 0.70